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1
The heart consists of four chambers: the left atrium and ventricle (LA and LV, respectively) and 
the right atrium and ventricle (RA and RV, respectively)(Figure 1). Deoxygenated blood from 
the systemic circulation enters the RA, moves through the tricuspid valve to the RV and then, 
through the pulmonary valve, to the lungs. After oxygenation, the blood moves to the LA and 
through the mitral valve, to enter the LV. Subsequently, it passes through the aortic valve and 
re-enters the systemic circulation.
Cardiac contraction is initiated by an electrical impulse. All chambers are electrically activated 
in an appropriate sequence through the cardiac conduction system (Figure 1). Normal cardiac 
activation starts in the sinoatrial node, in the RA. The activation wave then travels across 
both atria and, subsequently, through the atrioventricular node, which slows down conduction. 
Thereafter, the impulses continue into the His bundle, the first section of the specialized, high-
velocity conduction system of the ventricles. The His bundle then splits into a left and a right 
bundle branch. Conduction through these branches enables synchronized and fast activation 




















FIGURE 1. An overview of cardiac anatomy. AV node = atrioventricular node. Adapted from Marieb, EN and Keller, 
SM. Essentials of Human Anatomy and Physiology, 12th edition (2017).
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Bundle branch block
If one of the bundle branches is damaged, left bundle branch block (LBBB) or right bundle 
branch block (RBBB) occurs, and activation of the affected ventricle has to come about by 
means of conduction through the working myocardium. This type of conduction is considerably 
slower (~0.5 m/sec, while conduction through the His bundle occurs at 1-3 m/sec1,2), meaning 
that both activation and contraction of the affected ventricle (and in particular, its free wall) are 
delayed3.
In the case of LBBB the early-activated septum contracts prior to the other areas. Therefore, 
the septum contracts against a relatively low pressure in the LV, and performs little work4. 
Areas that are activated late, on the other hand, experience pre-stretch (caused by contraction 
of areas that are activated early), leading to activation of the Frank-Starling mechanism and 
stronger regional contraction. This, in turn, increases local work in late-activated regions4. In 
the case of RBBB, a similar cardiac activation pattern occurs in the RV5.
Such abnormal contraction patterns also lead to a loss of efficiency of contraction, because 
early-activated areas waste energy stretching late-activated areas, and vice versa4,6.
The dyssynchronous activation pattern has multiple consequences for the myocardium at 
the molecular and cellular level (see chapter 2 for more details). Broadly, we can split these 
remodelling consequences into three categories: structural (e.g. fibrosis and hypertrophy), 
electrical (e.g. changes in expression of connexin 43 and ion channels related to depolarization 
and repolarization) and contractile remodelling (e.g. changes in calcium handling and contractile 
proteins)4. At the organ level, these changes become apparent as, for example, asymmetric 
hypertrophy and cardiac dilatation4.
Over time, all aforementioned molecular and cellular derangements lead to worsened cardiac 
function and more severe conduction delay, starting a vicious circle that can culminate in heart 
failure4 (Figure 2, see chapter 2 for more details).
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FIGURE 2. Overview of the vicious circle of dyssynchrony. Reproduced from 4.
Cardiac resynchronization therapy: current 
concepts and unexplored territories
Cardiac resynchronization therapy (CRT) may reverse the vicious circle of dyssynchrony in 
hearts with LBBB, and possibly also RBBB7,8. This treatment involves implanting a pacemaker 
and placing the electrodes (leads) in the RA, the RV and an epicardial vein on the LV. Ventricular 
contraction is resynchronized by (almost) simultaneous stimulation from both ventricular 
leads. Such resynchronization can cause both acute and long-term improvements in cardiac 
function, which in turn lead to lower risk of heart failure hospitalisations and death, in particular 
in patients with heart failure and LBBB9–11.
CRT benefit can be explained by several types of favourable cardiac remodelling. For instance, 
improved calcium handling can have positive effects on both electrical and contractile 
properties4. At the organ level, a reduction in asymmetric hypertrophy and ventricular volumes 
may become visible4 (see chapter 2 for more details).
Over the last two decades CRT has become an accepted treatment for patients with heart 
failure and LBBB. However, several aspects are less well understood. First of all, while the 
effects of CRT on cardiac depolarization have been studied in considerable detail, much less 
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is known about the effects of CRT on repolarization. Furthermore, much is yet to be learned 
about the efficacy of CRT in structural heart disease, such as mitral regurgitation or congenital 
heart disease.
Repolarization and CRT
The effects of CRT on cardiac electrical activation (depolarization) have been studied extensively. 
However, several studies have found that CRT may also affect the electrical “deactivation” 
(repolarization) of the heart12,13. The effect of CRT on repolarization is particularly important 
since dispersion of repolarization has been linked to a higher risk of cardiac arrhythmias. 
The role of CRT in this matter seems somewhat ambiguous. An increase in repolarization 
dispersion with concomitant arrhythmia development after start of CRT has been reported by 
some14, while other studies examining patients after an upgrade from implantable cardioverter 
defibrillator to CRT did not find an increased occurrence of arrhythmias15,16. Additionally, 
patients who respond to CRT have a lower risk of developing arrhythmias, suggesting that 
beneficial electrical remodelling may occur17,18.
Regardless of the exact mechanism, alterations in cardiac activation patterns have indeed 
been found to induce electrical remodelling. These changes can be observed by studying the 
T wave of the electrocardiogram (ECG) and vectorcardiogram (VCG, Figure 3), both during 
prolonged CRT12,19 and during prolonged dyssynchrony (brought about by RV pacing or 
LBBB20–23). Shortly after onset of dyssynchrony an increase in T wave area and amplitude has 
been found21,23, which is indicative of a rise in dispersion of repolarization24. Subsequently, T 
wave area and amplitude decrease if dyssynchrony persists21–23.
Further evidence for electrical remodelling is observed when pacing from the RV is switched 
off and dyssynchrony is briefly halted (Figure 4). In that case, the opposite occurs: T wave 
size increases relative to its baseline value21. Moreover, its direction deviates from its initial 
orientation during normal activation, despite the fact that the pacemaker has been switched 
off21. Because the direction of the T wave follows the direction of the paced QRS complex this 
phenomenon has been named cardiac or T wave memory21,25.
In the case of CRT (so resynchronization) similar phenomena can be observed, including an 
acute increase in T area when the device is switched off12,19. However, until now, the time 
course of these electrical remodelling processes has not been studied in detail, nor has the 
relation with contractile remodelling been elucidated.
General introduction | 13
1
FIGURE 3. An electrocardiogram (ECG, left column) can be converted (using the Kors matrix, central table) to a 
vectorcardiogram (VCG, right column). A VCG expresses cardiac depolarization and repolarization over time in 
three dimensions. In this way, a VCG provides information about both direction and magnitude of cardiac electrical 
wavefronts. Light green and blue areas are subtracted from dark green and blue areas (right column), and total QRS 
and T areas are calculated using the formulas at the bottom. Adapted from 46 and 47.
FIGURE 4. Vectorcardiograms obtained in a dog during sinus rhythm (A), during ventricular pacing (B) and during 
sinus rhythm when the pacemaker has been switched off after a period of ventricular pacing (C). Ventricular pacing 
affects both QRS complex and T wave (B). When the pacemaker is switched off after a period of pacing, the T wave 
becomes larger and moves closer to the paced QRS complex direction over time (C, only the T wave is shown). 
mV = millivolt. Adapted from 48.
A B C
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Mitral regurgitation and CRT
The mitral valve consists of a ring of connective tissue (annulus) that encircles two leaflets. The 
leaflets are connected to papillary muscles close to the apex of the LV by chords of connective 
tissue, known as the chordae tendineae. Normally, the valve closes due to pressure build-up 
in the contracting LV while the papillary muscles pull on the chordae tendineae to keep the 
leaflets from protruding into the LA. Thus, blood is prevented from regurgitating into the LA 
(Figure 5A and B).
However, many patients who are candidates for CRT have some degree of mitral regurgitation 
(MR). This may be structural MR, caused by structural heart disease such as damage to the 
chordae tendineae (Figure 5C). On the other hand, LBBB can also lead to functional MR due 
to several mechanisms. For instance, less efficient LV contraction leads to a lower closing 
force on the mitral valve leaflets26. Moreover, the mitral valve annulus shape and the position 
of the papillary muscles may be abnormal due to ventricular dyssynchrony or dilatation, which 
may create a regurgitant orifice within the valve by impairing coaptation (closure) of the mitral 












FIGURE 5. A. During ventricular relaxation (diastole), blood (red arrows) enters the LV from the LA. B. During LV 
contraction (systole), the mitral valve closes due to the build-up of pressure by the LV and chordae tendineae 
keep the leaflets in place. Blood moves into the aorta. C. If chordae tendineae are ruptured, they cannot keep the 
mitral valve leaflet in place during systole, and blood regurgitates into the LA during LV contraction. MR = mitral 
regurgitation, LA = left atrium, LV = left ventricle. Adapted from Carpentier A, Adams DH and Filsoufi F. Carpentier’s 
Reconstructive Valve Surgery, 1st edition (2010). 
A B C
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Conceptually, the underlying cause of MR is important, since different causes may require 
different treatments27. CRT may be able to correct functional MR through several mechanisms26. 
For example, the more efficient cardiac contraction can increase the force with which the mitral 
valve leaflets are closed28 and resynchronization of the papillary muscles may result in improved 
positioning of the valve leaflets, optimizing valve closure29. Additionally, an improvement in the 
relative timing of atrial and ventricular contraction30 or a reduction in the size of the mitral orifice 
may reduce MR26. Beneficial effects can be observed both acutely and long-term, since reverse 
remodelling caused by CRT can lead to improved coaptation of the mitral valve leaflets through 
smaller LV volumes and better alignment of papillary muscles and chordae tendineae26.
However, in some patients CRT is not accompanied by improvement of MR. Such persistent 
MR is associated with poorer long-term cardiac function31,32 and (event-free) survival29,32,33. 
Nonetheless, even in the case of persistent MR CRT may be beneficial29,34,35. Further studies into 
the benefit of CRT in the presence of structural MR are needed to expand our understanding 
of these phenomena.
Tetralogy of Fallot
Recently, in addition to its beneficial effects on the LV in LBBB, CRT has also been explored in 
patients with RBBB36–38. A particular situation in which this has been attempted is after surgical 
repair of Tetralogy of Fallot (ToF). ToF is the most common type of cyanotic congenital heart 
disease, occurring in approximately 1 in 3600 live births39.
In patients with ToF, four abnormalities are present in the heart: ventricular septal defect 
(VSD), aorta overriding the VSD, right ventricular outflow tract obstruction (RVOTO) and right 
ventricular hypertrophy (Figure 6). If the RVOTO is sufficiently severe, blood is shunted from 
the RV into the LV, leading to reduced pulmonary blood flow and cyanosis, which is potentially 
life-threatening40.
During surgery, which is usually performed at a very young age, the VSD is closed with a 
patch and the RVOTO is resected, nowadays while preserving the integrity of the pulmonary 
valve as much as possible39. However, after surgery, a combination of pulmonary stenosis and 
regurgitation is often present. Furthermore, RBBB commonly occurs, either proximally, due to 
VSD closure, or more distally, due to the RVOTO resection or ventriculotomy41,42.











FIGURE 6. The four cardiac defects found in patients with Tetralogy of Fallot. Blood with little oxygen (blue arrows) 
is shunted into the LV through the ventricular septal defect. RA = right atrium, RV = right ventricle, LV = left ventricle. 
Adapted from 40.
This combination of RV pressure overload, volume overload and RBBB can lead to pathological 
RV remodelling and, eventually, to RV failure and cardiac arrhythmias40,42. Imaging and 
electrical mapping studies have revealed that patients with repaired ToF (rToF) show both 
mechanical and electrical dyssynchrony, suggesting that resynchronization of the RV could 
be beneficial42–44. However, CRT requires normal myocardial conduction properties, since the 
presence of scar can reduce its efficacy45. Conversely, presence of conduction blocks in the 
RV might hamper the benefit of CRT. Whether this phenomenon also occurs in patients with 
rToF has not yet been investigated in detail.
Aims of the thesis
The bulk of CRT research has been conducted in the context of resynchronization of 
depolarization during LBBB. As the title of this thesis implies, our aim is to investigate aspects 
of CRT beyond the well-known resynchronization of activation and contraction, both in terms 
of its application and its consequences.
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We aimed to answer the following questions:
1) What is the time course of repolarization changes following CRT, and how does 
dispersion of repolarization change after CRT?
2) Is there a link between repolarization changes and response to CRT?
3) May CRT still be beneficial in the context of structural MR?
4) Do myocardial conduction properties in patients suffering from rToF suggest a 
favourable substrate for CRT?
Outline of the thesis
In chapter 2 we review the pathobiology of dyssynchrony and its correction by resynchronization, 
covering both clinical aspects and molecular mechanisms.
In chapter 3 we study the time course of repolarization changes in relation to contractile 
remodelling by analysing serial ECGs and echocardiograms from patients who received CRT. 
Moreover, we explore the consequences of this repolarization remodelling for dispersion of 
repolarization using a computer model of cardiac depolarization and repolarization.
In chapter 4 we investigate whether repolarization remodelling is more prominent in CRT 
responders (patients showing a large increase in LV ejection fraction) than in non-responders, 
by examining ECGs and echocardiograms recorded prior to CRT implantation and after 
approximately 6 months of treatment.
In chapter 5 we describe the acute effects of CRT in two dog models: one of MR+LBBB and 
one of isolated LBBB. We compare the haemodynamic effects (effects related to blood flow 
and pressure) of various pacing modes in these animal models. Moreover, we assess changes 
in cardiac function over time during both LBBB and MR+LBBB.
Chapter 6 examines myocardial conduction properties in a small group of patients with rToF 
and in several non-rToF patients. These patients underwent epicardial electrical mapping (on 
the outside of the heart) of both ventricles and endocardial mapping (on the inside of the 
heart) of the RV, during medically indicated cardiac surgery. We investigated whether structural 
conduction blocks occurred by comparing activation patterns recorded during sinus rhythm 
and during ventricular pacing.
The final section of this thesis (chapter 7) is a general discussion, in which our findings are 
discussed in a broader scientific perspective. Moreover, we describe the potential scientific 
and clinical impact of our work.
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Abstract
Synchronous ventricular electrical activation is a prerequisite for adequate left ventricular (LV) 
systolic function. Conduction abnormalities such as left bundle branch block (LBBB), and 
ventricular pacing lead to a dyssynchronous electrical activation sequence, which may have 
deleterious consequences.
The present review attempts to connect the various processes involved in the development of 
“dyssynchronopathy” and its correction by cardiac resynchronization therapy (CRT). Abnormal 
electrical impulse conduction leads to abnormal contraction, characterized by regional 
differences in timing as well as shortening patterns and amount of external work performed. 
Early-activated regions may show “wasted work” which leads to inefficient action of the entire 
LV. Moreover, both the development of heart failure in general and the regional differences in 
mechanical load lead to structural, electrical, and contractile remodelling processes. These 
have been demonstrated at the level of the myocardium (asymmetric hypertrophy, fibrosis, 
prolongation of activation and reduction in repolarization forces, decrease in LV ejection fraction), 
cell (gap junctional remodelling, derangement of the T-tubular structure) and molecule (under- 
or overexpression of ion channels and contractile protein subtypes and abnormal calcium 
handling). The myocardial adaptations to dyssynchrony are “maladaptive”. This also explains 
why CRT, unlike most pharmacological treatments, continues to increase its therapeutic effect 
over time. Finally, better understanding of all processes involved in dyssynchrony and CRT 
may also lead to new pharmacological agents for treating heart failure and to novel pacing 
strategies.
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Introduction
Proper cardiac pump function is dependent on fairly synchronous and well-distributed 
electrical activation. The intraventricular rapid conduction system plays a key role in this 
respect. The importance of this synchronous activation is illustrated by the deviations in 
structure and function that occur when impulse conduction becomes abnormally slow, as 
is the case during ventricular pacing and left bundle branch block (LBBB). Slow impulse 
conduction leads to large time differences in electrical activation and contraction within a 
ventricle and between the ventricles (intra- and interventricular dyssynchrony, respectively). The 
combination of all detrimental changes leading to dyssynchrony-induced cardiomyopathy can 
be termed “dyssynchronopathy”, a disease that can be treated by cardiac resynchronization 
therapy (CRT). The present overview aims to review and discuss current knowledge on the 
pathobiology of dyssynchrony and CRT, i.e. the causes and consequences of dyssynchrony 
and resynchronization for structural and functional processes in the myocardium.
Electrical aspects
The pathobiology of conduction abnormalities and electrical 
dyssynchrony
Synchronous ventricular electrical activation is a prerequisite for adequate left ventricular (LV) 
function. In the healthy heart this is achieved by propagation of electrical impulses from the 
atrioventricular node through the fast-conducting His-Purkinje system. An additional role may 
be played by fast-conducting endocardial fibers, which conduction velocity is in between that 
of working myocardium and Purkinje fibers1. Of note, functionality of such fibers has only 
been demonstrated in the dog heart, the conduction system of which seems to be closest to 
the human heart of all non-primate mammals2. “True” Purkinje fibers are characterized by a 
larger size2 and by overexpression of connexin 43 (Cx43)3 compared to endocardial fibers. In 
relatively simple histological images, the subendocardial fibers in the dog heart appear uniformly 
oriented but otherwise similar to working myocardium1. Such fibers have not been identified in 
the human heart, but high resolution micro computed tomography (CT) images show dense 
networks of Purkinje-like fibers, which may be comparable to the fast-conducting endocardial 
fibers in the dog heart. In the dog heart several studies showed fast impulse conduction along 
the LV endocardium4, 5 apparently explaining the benefit of endocardial CRT4, 6, 7. Although the 
existence of fast-conducting subendocardial fibers in the human heart is not clear, clinical 
studies support the evidence that endocardial CRT is at least as beneficial as epicardial CRT8.
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While the ventricular endocardium is normally electrically activated within ~20 ms, the 
remaining transmural propagation from endocardium to epicardium requires another ~50 ms9. 
The Purkinje system may be damaged or bypassed during conduction abnormalities such 
as LBBB and ventricular pacing. Under these conditions, conduction propagates primarily 
through working myocardium in which the conduction velocity is almost four times slower 
compared to the specialized His-Purkinje system9. Additionally, the wavefront of activation 
changes. Propagation perpendicular to the fiber orientation is half of that of propagation 
parallel to the fibers10, contributing to the prolongation of total ventricular activation.
While the cause of abnormal conduction during ventricular pacing is obvious, this is much 
less the case during bundle branch block. Especially during LBBB, the conduction block 
may occur at any level in the His-Purkinje system. The wide variation in left bundle branch 
anatomies further complicates the diagnosis of LBBB11. LBBB may develop suddenly when its 
primary blood supply is obstructed or under iatrogenic circumstances, for instance after aortic 
valve replacement. In the latter case, the block is obviously proximal in the left bundle branch. 
However, more often, LBBB is a result of slow degeneration of the conduction system due to 
chronic conditions affecting the myocardium12.
There is interesting and growing evidence that, in the latter case, a considerable part of LBBB 
patients has a proximal block. This evidence comes from the fact that His bundle pacing 
creates significant narrowing of the QRS complex in many patients with LBBB. Because this 
effect can only be explained if pacing occurred distal to the block, this LBBB should be located 
very proximal in the His bundle or even in the lower part of the atrioventricular (AV) node. 
Forty-year-old studies already pointed this out13, 14, and results were explained by the theory 
of longitudinal dissociation of the His bundle. This theory assumes that the conducting fibers 
to the right and left bundle branch are histologically isolated inside the trunk. Injuring the trunk 
may lead to a complete AV-block or a bundle branch block15. Stimulation of the fibers distal to 
the bundle branch block can normalize the QRS complex in case of pure His bundle capture 
and absence of pre-excitation of adjacent myocardium. More recent studies demonstrating 
ventricular resynchronization through His bundle pacing in CRT candidates reinforced this 
idea16.
Electro-anatomic insights in the pathobiology of electrical 
dyssynchrony
After the first crude mapping studies in LBBB and right ventricular (RV) paced patients by 
Vasallo et al. in the 1970s17, detailed mapping studies were performed by Auricchio and 
associates18, 19. These studies showed that LBBB was characterized by a slow impulse 
conduction originating from the RV free wall gradually propagating to the LV lateral wall19. 
Interestingly, a large variation in transseptal conduction time (TST) was present in patients 
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referred for CRT. While a few patients almost had simultaneous activation at the RV and LV 
side of the septum (TST near 0), most of the patients with LBBB showed TSTs of >30 ms, 
even up to 80 ms20. Long TSTs were also found in canine LBBB hearts, especially in canines 
with LBBB and tachypacing-induced heart failure (HF)21. Slow transseptal conduction is also 
evident from epicardial contact maps in ventricular paced canine hearts7 and from non-invasive 
electrocardiographic imaging (ECGI) maps in LBBB patients (Figure 1)22. The slow conduction 
across the septum may be explained by its transverse conduction perpendicular to the fiber 
orientation. However, this is also the case in conduction from endocardium to epicardium of the 
LV free wall and this conduction is still faster than across the septum10. Apparently, the septum 
has specific structural abnormalities that slow down conduction, especially after remodelling 
due to HF. The slow septal conduction reflects an electrical separation between activation of 
the RV and LV, which is proposedly responsible for QRS notching on the electrocardiogram 
(ECG) characteristic for LBBB23.
FIGURE 1. Overview of electrical dyssynchrony metric approaches. In the ECG imaging and contact mapping panels 
colour differences within the ventricles represent intraventricular dyssynchrony, whereas the mean difference in colour 
between the ventricles reflects interventricular dyssynchrony. ECG = electrocardiogram, VCG = vectorcardiography, 
UHF = ultra-high frequency.
Non-invasive assessment of electrical dyssynchrony
Much information about ventricular conduction abnormalities has been obtained using the 
12-lead ECG. QRS duration ≥150 ms and a LBBB morphology on the ECG indicate a class 
1A recommendation for CRT implantation24. However, QRS duration cannot distinguish 
between right- or left-sided conduction abnormalities and between inter- and intraventricular 
dyssynchrony. While QRS morphology provides more information, it is prone to subjective 
interpretation and there are multiple definitions for specific conduction disturbances such 
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as LBBB. For example, in a small retrospective study of different LBBB criteria in patients 
receiving CRT, a 23% disagreement in LBBB classification was found between the European 
and American guidelines25.
During recent years, multiple non-invasive techniques have been developed that allow more 
precise analysis of electrical dyssynchrony by incorporation of spatial or temporal information. 
First of all, there are techniques closely related to the conventional 12-lead ECG, such as 
vectorcardiography (VCG) and ultra-high frequency ECG that can be easily implemented in 
clinical practice26, 27. A more complicated technology, ECGI, reconstructs the electro-anatomic 
activation of the epicardium based on body surface potential measurements using ~200 
electrodes around the chest and a patient-specific heart-torso geometry28. ECGI allows 
assessment of both inter- and intraventricular dyssynchrony22. Interestingly, it was shown that a 
parameter describing interventricular dyssynchrony correlates better with CRT response than 
parameters of intraventricular dyssynchrony; an observation that was subsequently supported 
by computer simulations22, 29.
An intermediate approach between the conventional 12-lead ECG and the extensive ECGI 
is the ECG-belt, where 53 chest electrodes are used. The standard deviation of all ECG-
belt-derived activation times (SDAT) has been proposed as a novel electrical dyssynchrony 
metric reflecting electrical heterogeneity. In 66 CRT recipients SDAT, but not QRS duration or 
morphology, was associated with LV end-systolic volume (LVESV) reduction and increase of 
LV function upon starting CRT30. An overview of the aforementioned electrical dyssynchrony 
assessment techniques is provided in Figure 1.
Mechanics of the dyssynchronous ventricle
A close relationship exists between excitation and contraction in both the normal31, 32 and 
failing heart33, 34. The latter was most clearly demonstrated by the use of 3D electromechanical 
mapping, which allows measuring strains and electrical activation at exactly the same position33.
This coupling between excitation and contraction makes it understandable that dyssynchronous 
electrical activation leads to dyssynchronous ventricular contraction. These contraction 
abnormalities are complex, as illustrated in Figure 2. Early shortening in early-activated 
regions is followed by a systolic rebound stretch, sometimes showing a bi- or triphasic 
pattern. In contrast, late-activated regions are subjected to early-systolic prestretch, followed 
by augmented systolic shortening that continues into diastole. The most likely physiological 
explanation for these patterns is that early contraction stretches the not-yet depolarized 
late-activated regions and that this prestretch activates the local Frank-Starling mechanism 
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and subsequently creates a supranormal contraction in late-activated regions. Possibly the 
best support for this idea are results from simulations in the CircAdapt computer program. 
In this model, the ventricles are represented by three wall segments (RV, septum and LV free 
wall), which contain the property of length-dependent activation. Simply delaying LV free wall 
contraction results in strain patterns in septum and LV free wall that are close to those observed 
in LBBB patients (Figure 2A)35.
FIGURE 2. A. Effect of dyssynchronous ventricular activation on mechanical dyssynchrony indices in the CircAdapt 
model. Computer simulations were performed to predict LV septal and lateral wall strain curves after inducing LVFW 
delays in increasing severity. B. Strain patterns measured in a patient before (left) and during CRT (right). Red lines 
indicate systolic shortening, green early systolic prestretch and blue septal rebound stretch. The bar graphs indicate 
that CRT reduces septal rebound stretch and increases systolic shortening of the septum (thick lines) and LVFW (thin 
lines) combined. AVC = aortic valve closing, AVO = aortic valve opening, CRT = cardiac resynchronization therapy, 
EJ = ejection, IntraVDA = intraventricular delayed activation, IC = isovolumic contraction, IR = isovolumic relaxation, 
LV = left ventricle, LVFW = left ventricular free wall, MVC = mitral valve closing, MVO = mitral valve opening, RV = right 
ventricle, SEPT = septal. Adapted from 140(A) and 37(B).
A
B
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Assessment of mechanical dyssynchrony
The analysis of mechanical dyssynchrony has developed rapidly over the last two decades. 
Initially tissue Doppler imaging was used36, while more recently, techniques to measure strains 
(length changes) emerged, such as speckle tracking echocardiography37, 38, cardiac magnetic 
resonance imaging (CMR) tagging31, 39 and more recently feature tracking CMR40 and CT-
SQUEEZ41. However, still none of the guidelines recommend these techniques for selection of 
CRT patients. This is explained by the results of randomized clinical studies investigating the 
use of mechanical dyssynchrony for improving the selection of patients for CRT. Mechanical 
dyssynchrony had no additional predictive power on top of ECG parameters in cohorts of 
patients with a wide QRS complex42, 43, whereas neutral or even negative results were found 
when mechanical dyssynchrony was used as the only selection criterion in patients with a 
narrow QRS complex44, 45.
In part, these poor results can be explained by limitations of tissue Doppler imaging46 and 
the strong operator dependency of acquisition and analysis of echocardiographic images. On 
the other hand, considerable differences in time to peak shortening may not only be caused 
by electrical dyssynchrony but also by regions with low contractility and scar47. Furthermore, 
peak shortening delay has at best a semi-quantitative relation with true dyssynchrony (Figure 
2A). On the other hand, several studies showed the strength of relatively simple measures 
of dyssynchrony, such as apical rocking and septal flash do improve prediction of CRT 
response48-50. Further improvements were made by using the analysis of strain patterns51, 
resulting in parameters such as CURE52, septal systolic rebound stretch37, 53, and systolic 
stretch index47.
Functional consequences of mechanical dyssynchrony
A direct consequence of ventricular dyssynchrony is the reduction in LV function. The gold-
standard way to assess LV function is to determine pressure-volume (PV) loops. Immediately 
after the onset of dyssynchrony, the PV loop shows a rightward shift, indicating that the LV 
needs to operate at a larger volume in order to generate the same pressure; furthermore, 
stroke volume decreases54. The reverse process has been observed upon starting CRT in 
patients55. This poorer pump function is largely caused by the reduced systolic shortening 
in early-activated regions, which is hardly compensated by an increase in shortening in late-
activated regions, at least during the ejection phase. As a consequence, in LBBB hearts septal 
rebound stretch is a good predictor of CRT response37.
Such septal stretch during systole implies that this region dissipates energy that was generated 
in opposing regions56, 57. In this respect Russell et al. introduced the term “wasted work”57, 58. 
Using an elegant method, these investigators were able to show that the ratio of wasted 
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and positive work predicts CRT response57. Importantly, the same research group recently 
showed that increasing afterload increases the amount of wasted work and disproportionally 
reduces global longitudinal strain and LV ejection fraction (LVEF)59. This finding suggests that 
the dyssynchronous heart is more sensitive to additional increases in cardiac workload than 
synchronous hearts and that the afterload should be taken into account when quantifying 
mechanical dyssynchrony.
The acute hemodynamic benefit of CRT can be understood from its correction of 
electromechanical dyssynchrony. Certainly in the heart with LBBB, CRT achieves a great deal 
of normalization of strain patterns and almost vanishing of septal rebound stretch37 and wasted 
work57.
A further consequence of the wasted work in the dyssynchronous heart is that the efficiency 
of conversion of metabolic energy (myocardial O2 consumption) to mechanical energy (stroke 
work) at the level of the entire LV can be up to 30% lower during LBBB or RV pacing as 
compared to normal activation60. Conversely, CRT increases ventricular efficiency, which 
translates into a lower myocardial perfusion requirement for the same amount of pump work 
performed61-63 and into a larger perfusion reserve64. Because many CRT patients may also have 
compromised coronary perfusion, CRT may also lower the risk or amount of underperfusion. 
This all may explain why wasted work65 and the work ratio between the septum and LV free 
wall66 are good predictors of CRT response.
A third consequence of dyssynchrony is the considerable redistribution of myocardial work 
within the ventricles. Because systolic shortening (so shortening against a pressure) in the 
septum is approximately zero, external work is also zero. In contrast, systolic shortening and 
external work are supranormal in the LV lateral wall (Figure 2). Accordingly, also myocardial 
blood flow is redistributed, both in experimental LBBB models67, 68 and in patients62. The fact 
that this redistribution is reversed by CRT, concurrent with the homogenization of local strains 
and work68 indicates that workload drives flow and not the other way around. Earlier work of 
Amitzur supports this view by showing that administration of adenosine in RV paced hearts 
changes local blood flow but not contraction patterns69.
Figure 3 summarizes how the various acute consequences of dyssynchronous electrical 
activation, mentioned above, lead to worsening cardiac function and ventricular dilatation. In 
clinical terms, the diminishment of systolic function is evidenced by a lower LVEF and lower 
strains, worse diastolic function by reduced diastolic filling times and the dilation is shown by 
a larger LV end-diastolic volume and a rightward shift of the PV loop in conductance catheter 
measurements55.






















FIGURE 3. Schematic representation of maladaptive processes following the onset of dyssynchronous activation 
(see text for details).
Remodelling: from myocardium to molecule
Figure 3 also depicts that “dyssynchronous HF” leads to unique and extensive gene and 
protein expression patterns that can be linked to structural as well as electrophysiological 
and contractile changes70-72. These “remodelling processes” are driven by neurohumoral 
factors, like adrenergic stimulation and activation of the renin-angiotensin-aldosterone system 
(RAAS), and by the mechanical load on the heart itself73. Although the exact mechanisms for 
transmitting mechanical load to the myocardial cells are not clear74, stretch is a well-known 
trigger for changing cellular and organ function, both in vitro and in vivo54, 75-77. Typically, in 
LBBB, the early systolic prestretch and augmented external work in late-activated regions 
seem logical explanations for the frequently more pronounced remodelling processes in these 
regions.
Because in-depth understanding of (reverse) remodelling processes requires invasive 
procedures, like biopsies, most knowledge in the field of dyssynchrony and resynchronization 
is derived from various animal models of dyssynchrony78. The most straightforward way is 
to induce dyssynchrony by RV pacing or by LBBB, induced using radio frequency ablation 
while maintaining a normal heart rate. However, since such dyssynchrony reduces pump 
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function but does not lead to HF within a period of half a year67, several groups have added an 
increase in heart rate, ranging from 120 to 220 bpm for a period of 3-4 weeks to 24 months79, 
80. In all these models, resynchronization has been employed using biventricular pacing. 
Importantly, studies with tachypacing dyssynchronous HF also use tachy-biventricular pacing 
to resynchronize, which will be referred to as tachy-CRT. Tachy-CRT hardly improves functional 
parameters like LVEF, but reveals many changes at the cellular and molecular level presumably 
as a consequence of the better coordination of contraction81, 82.
Structural remodelling
In patients with dyssynchronous HF, CRT induces reverse remodelling with a reduction in 
LVESV83, 84 and reduced fibrosis85, 86. CRT responders (defined by LVESV reduction) were also 
shown to have a decreased LV mass and regional wall thickness, with improved LV geometry, 
as determined by the sphericity index87, 88. An interesting observation is that polymorphisms in 
the mineralocorticoid receptor gene proved an important determinant for reverse remodelling 
in CRT patients89, 90. This supports the view that the RAAS is strongly involved in the 
remodelling process in dyssynchronous failing hearts. These clinical studies suggest that the 
capability to reverse the remodelling is an important determinant of long-term CRT response. 
It seems reasonable to suggest that the overall decrease in LV wall mass and the reduced 
fibrosis upon CRT are mediated by the improved LV systolic function. A reduction in LV cavity 
volume decreases wall stress and, together with the increased LV function, potentially lowers 
neurohumoral activation. The reduction in workload in the late-activated LV free wall may be 
responsible for the excess reduction in LV free wall mass.
Animal models of LBBB with natural heart rate show ventricular dilatation in combination with 
asymmetric hypertrophy, the most pronounced hypertrophy occurring at sites of late activation54, 
68. The presence of this asymmetric hypertrophy (measured both by echocardiography and 
post-mortem histology54, 91) is accompanied by local molecular changes such as decreased 
miR133a expression and overexpression of connective tissue growth factor (CTGF) selectively 
in the LV lateral wall91. These local changes and their reversal upon applying CRT68, 91 are a 
strong indication of the importance of local mechanics for remodelling, because all regions 
of the dyssynchronous heart are subjected to the same neurohumoral stimulation. While the 
increase in LV cavity volume after onset of LBBB may directly follow the loss in LV systolic 
function (Figure 3), further LV dilatation may be mediated by changes in the extracellular 
matrix (ECM) properties and matrix metalloproteases (MMPs). This fits with the finding of 
ECM-remodelling and increased MMP activity in the LV free wall of RV-paced dogs92 and in 
dogs with tachypacing-induced dyssynchronous HF80, 93. The RV-pacing study also showed 
ECM accumulation (fibrosis) in the late-activated LV free wall92. By contrast, in dog-models 
of dyssynchrony without significant cardiac dysfunction (LBBB or LV pacing), myocardial 
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collagen content was not affected54, 91, 94, although this did occur in a study of tachypacing-
induced dyssynchronous HF80. In patients, a modest reduction in fibrosis was observed after 
CRT85, 86, which may be explained by a lower neurohumoral activation. Also, expression of 
paracrine factors contributing to fibrosis or hypertrophy, including osteopontin, transforming 
growth factor beta (TGFβ), CTGF and B-type natriuretic peptide (BNP), is increased during 
dyssynchrony and (partly) normalized by CRT91, 93, 95.
Besides cardiomyocyte hypertrophy and ECM accumulation, apoptosis contributes to 
the cardiac remodelling process in dyssynchronous HF. An overall increase in various pro-
apoptotic factors (such as caspases) has been shown in dyssynchronous HF96, 97. This pro-
apoptotic state is ameliorated by CRT and the regional variance in the expression of several 
stress-kinases is reduced96. The pro-apoptotic factor tumour necrosis factor alfa (TNFα) is 
increased in animal models of dyssynchrony96, 98 and in patients eligible for CRT86. In the animal 
model, the most pronounced increase in TNFα levels occurs in the LV free wall, with tachy-
CRT partially normalizing TNFα expression96. In accordance with this, also patients show 
reduced TNFα levels following CRT85, 86. Moreover, DNA fragmentation, a marker of apoptosis, 
is increased in dyssynchronous HF and reduced by CRT85, 96, 97. Interestingly, increased DNA 
fragmentation occurs in both the septum and the LV free wall and tachy-CRT is capable of 
reducing the occurrence of this process in both locations96.
Electrical remodelling
Electrical remodelling in dyssynchronous and resynchronized hearts may affect the sequence 
of both depolarization and repolarization.
Changes in the depolarization sequence have been observed from the broadening of the 
QRS complex during longer-lasting dyssynchrony in animal models54, 67. Similarly, longer-
lasting CRT has been reported to decrease QRS duration (both the paced and the non-paced 
QRS complex) in patients99. Beside changes in the gross anatomy (changes in LV mass and 
diameter and degree of fibrosis) discussed above, also changes in ion channels may play a 
role. Figure 4A schematically illustrates the contribution of the various ion channels to the 
ventricular action potential.
Cx43 is the main gap junction protein responsible for sodium influx during phase 0 of the action 
potential and subsequently conduction velocity. Increased lateralization of Cx43 in the LV is 
associated with remodelling processes after tachypacing-induced HF and after myocardial 
infarction (Figure 5)100, 101. Interestingly, electrical dyssynchrony by itself already influences 
Cx43 localization. In the lateral segments of the canine LBBB heart, a reduced endocardial 
conduction velocity was observed in combination with lateralization of Cx4394. Lateralization of 
Cx43 may lead to a more zig-zag conduction pattern102, and consequently slower conduction, 
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heterogeneity of refractoriness, and increased risk of reentry circuits. In addition, in canine 
hearts with tachypacing-induced HF both lateralization and decreased expression of Cx43 were 
associated with slowing of His-Purkinje conduction (Figure 4B)103, indicating that remodelling 
processes secondary to HF alone already prolong QRS duration.
Another factor contributing to conduction and cardiac excitation is the fast-inward voltage-
dependent sodium channel (INa), but its role in dyssynchrony is equivocal. INa density was 
decreased in explanted human hearts with HF104, but contradictory results have been reported 
for canine hearts with tachypacing-induced HF104,105.
FIGURE 4. A. Schematic overview of the five phases of the action potential, ECG, and ion channels involved. 
The action potential consists of: phase 0 (upstroke), phase 1 (fast early repolarization), phase 2 (plateau), phase 
3 (repolarization), and phase 4 (resting membrane potential). B. ECG and His electrograms demonstrating an 
increase in HV-interval and QRS duration after tachypacing-induced heart failure in canine hearts (adapted from 103). 
ECG = electrocardiogram.
While changes in the QRS complex reflect changes in depolarization, T wave changes 
reflect altered repolarization. In this respect, “cardiac memory” is of interest. Cardiac memory 
refers to persistent T wave changes on the ECG during restoration of normal ventricular 
activation sequence after a period of abnormal ventricular activation. These persistent T 
wave abnormalities indicate that the sequence of repolarization adapts to a new activation 
sequence106. This phenomenon has been studied in animals and humans107, 108. In patients 
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with RV pacing, changes in T wave amplitude and duration were already present within one 
day of pacing and became persistent after one week109. Similar cardiac memory phenomena 
developed between one day and two weeks of CRT110. Interestingly, animal studies showed 
that cardiac memory could be suppressed by mechanical unloading of the heart107. At the 
molecular level, involvement of the L-type calcium channel111 and the cyclic adenosine 
monophosphate response element binding protein, a factor heavily involved in regulation of 
gene expression, was shown112. These results strongly argue that the ventricular repolarization 
changes underlying cardiac memory are related to the mechanical consequences of the 
activation sequence (“mechano-electrical feedback”).
While the T wave changes in the setting of cardiac memory are indicative of changes in action 
potential duration (APD), such APD changes have indeed been observed in normal animal 
hearts during longer-lasting periods of ventricular pacing113. These studies showed APD 
lengthening in early-activated regions and gradual APD shortening towards later-activated 
regions. However, in the very latest-activated regions the APD lengthened in the dog heart114, 
whereas it was shortened in rabbit hearts113.
Commonly, the upright “concordant” T wave in the normal ECG is explained by late-activated 
regions having a shorter APD than early-activated regions115. While cardiac memory indicates 
some potential of the ventricles to adapt APD to activation sequence, the usually discordant 
T wave in hearts with RV pacing and LBBB suggests that this potential to adjust APD is 
insufficient in case of severe dyssynchrony. However, studies in patients without HF show 
that during longer-lasting dyssynchrony (RV pacing and LBBB), the amplitude of the T wave 
decreases over time108, 116, 117, suggesting some adaptation to the abnormal conduction. 
However, a recent electrical mapping study in HF patients showed that, regardless of QRS 
duration and morphology, the sequence of repolarization largely follows the sequence 
of activation, pointing towards reduced “capacity” of failing myocardium to adjust APD to 
abnormal activation sequence118.
Concordant with the experimentally observed role of the L-type calcium channel in cardiac 
memory, data from tachypaced dyssynchronous dog hearts show differential expression and 
current flow of this calcium channel, with lower values in the LV lateral than in the anterior wall81. 
However, while larger L-type calcium currents are expected to prolong APD, in the same study 
APD was shorter in myocytes from earlier-activated LV anterior wall regions81. The investigators 
explain this paradox by referring to the slower decay in the current in the LV lateral wall. In 
addition, the severe, but uniform reduction in various potassium channels (important during 
phase 3 and 4 of the action potential, Figure 4A), may change the influence of the various ion 
channels during the repolarization phase81.
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Computer model studies investigated how to reconcile the aforementioned mechano-electrical 
feedback, observed in cardiac memory studies, and the electrical and contractile remodelling 
in dyssynchronous hearts. It was assumed that mechano-sensing aims to maintain a constant 
mechanical function (like strain), and that adjustments occur through varying activity of the 
L-type calcium current81. According to the computer simulation, a reduction in local mechanics 
in early-activated regions was followed by increased activity of the L-type calcium channel119. 
During small time differences in activation (e.g. sinus rhythm), this adaptation process was able 
to lead to the well-known concordant T wave119. In the dyssynchronous ventricle, T waves 
only became less discordant over time120, much like what has been observed in patients (see 
above).
Clearly, our understanding of electrical remodelling processes influencing ventricular 
repolarization in the dyssynchronous heart is incomplete. Beside factors discussed above, also 
the poor understanding of electrotonic influences on repolarization in vivo and of the relation 
between APD heterogeneity and T wave morphology should be recognized115, 118.
Contractile remodelling
Dyssynchrony results in acute negative effects on LV contractile function in animals68 and 
patients121. Moreover, a study in patients with normal LVEF showed that RV pacing immediately 
reduces LVEF by ~6%, followed by a further ~8% during the subsequent week of RV pacing. 
Full recovery of LVEF after termination of pacing took 2 days, further indicating some kind 
of contractile remodelling122. Similarly, CRT reverses some of the contractile defects beat-to-
beat123, 124 and continues to do so over years68, 125.
While the acute hemodynamic effects can be explained by changes in mechanical coordination, 
as explained above, the chronic effects seem mediated by subcellular and molecular changes4. 
In this regards calcium probably plays a dual role, also being involved in electrical remodelling. 
As mentioned above, in the tachypacing model LBBB led to a significant and regionally different 
reduction in the L-type calcium current and this disparity was resolved by tachypacing CRT81. 
L-type calcium current densities were also reduced in ventricular myocytes from a minipig 
model of RV pacing, compared to controls126.
Also, other proteins involved in calcium handling may play a role in contractile remodelling. 
Patients with ischemic or idiopathic dilated cardiomyopathy show reduced sarcoplasmatic 
reticulum (SR) Ca2+ ATP-ase (SERCA) activity compared to controls127. Lower SERCA 
expression was found in patients who are eligible for CRT95 and CRT increases SERCA 
expression128, 129. Vanderheyden et al. showed that the increase in SERCA only occurs in CRT 
responders95. Several128, 129, albeit not all studies report an increase in phospholamban (PLN) 
levels after CRT95.
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These clinical data fit with observations of reduced SR calcium uptake in a porcine model of RV 
pacing98 and downregulation of SERCA in tachypaced81 and non-tachypaced130 dog hearts. 
In one study, the change occurred in the LV free wall but not in the interventricular septum130. 
In the LV free wall of tachypaced dyssynchronous HF a reduction in SERCA expression was 
selectively found in the endocardium, leading to a steep transmural expression gradient79. After 
tachy-CRT, SERCA was no longer significantly downregulated in either early- or late-activated 
myocardium81. Slightly smaller, but still significant reductions were observed for PLN in both 
tachypaced and non-tachypaced canine models of dyssynchrony81, 130, but not in a porcine 
model98.
An upregulation of the sodium-calcium exchanger (NCX) was found in animal models of (tachy)-
dyssynchrony81, 98 and a similar trend could be observed after CRT in patients129.
These molecular changes may relate to subcellular changes. In patients, abnormalities in 
T-tubular structure have been linked to impaired contractility131. In the LV lateral wall of the 
tachypacing LBBB model, regression of the T-tubular system has been reported, which was 
partially reversible upon tachy-CRT132, 133.
An important role in the contractile remodelling processes may also be reserved for the 
autonomic nervous system. The response to β-adrenergic stimulation is diminished in patients 
with HF134. CRT treatment recovers the β-adrenergic response135.
On the cellular level, the contractile response to β-adrenergic stimulation (increase in calcium 
transient, cellular shortening) is reduced in HF136, which may be (partially) explained by 
downregulation of the β1 and β2 adrenergic receptors137, 138. In tachypaced dyssynchronous 
HF, tachy-CRT normalizes the response in cells from both anterior and lateral LV wall137, 
138. Interestingly, most studies, in both patients129 and animals137, 138, demonstrate that CRT 
upregulates the β1-, but not the β2-receptor. In addition, a unique feature of β2-receptor 
signaling is observed during dyssynchrony, namely an increased G-protein alpha-I (Gαi) 
coupling, leading to reduced adenylyl cyclase activity and thus lowering cyclic AMP (cAMP) 
production. This contributes to decreased contractile function. Upon resynchronization, the β2 
receptor becomes uncoupled from these Gαi proteins and restores Gαs signaling137. This this 
mechanism may also be active in CRT responders137.
Also at the level of the myofibrils some remodelling may be present, for instance in myosin 
heavy chain α (MHCα). In patients, dyssynchronous HF is associated with reduced expression 
of MHCα and this reduction seems reversed by CRT95, 128. The CRT-induced MHCα increase 
correlated with the reduction in cavity dimensions128.
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Studies in skinned muscle fibers from animals with tachypacing-induced HF showed yet 
another mechanism of contractile modulation: calcium sensitivity of the myofilaments. This 
sensitivity was shown to be reduced in dyssynchronous HF due to glycogen synthase kinase 
(GSK)-3β–dependent phosphorylation of contractile proteins. Tachy-CRT restored calcium 
sensitivity through increased GSK3-β activity139.
Summarizing, a large range of processes seem responsible for the contractile remodelling 
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FIGURE 5. Processes contributing to the structural, electrical, and contractile remodelling in the dyssynchronous 
heart as seen on functional measurements (left) and on a cellular and molecular level (right). Red colour indicates 
the situation during dyssynchrony. Dyssynchrony causes asymmetric, eccentric hypertrophy and (in the failing 
heart) fibrosis as well as apoptosis. Some of the molecular factors are mentioned. Similarly, some of the processes 
involved in altered excitation-contraction coupling are displayed in the inset, illustrating a part of the plasmalemma, 
T-tubule and sarcoplasmic reticulum. See text for further details. BNP = B-type natriuretic peptide, CRT = cardiac 
resynchronization therapy, CTGF = connective tissue growth factor, Cx43 = connexin 43, LBBB = left bundle branch 
block, LVfw = LV free wall, MHCα = myosin heavy chain α, MMPs = matrix metalloproteases, OPN = osteopontin, 
PLN = phospholamban, SR = sarcoplasmic reticulum, SERCA = SR Ca2+ ATP-ase, TGFβ = transforming growth 
factor β, TNFα = tumour necrosis factor α.
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Conclusion
This review illustrates that conduction abnormalities (such as LBBB) lead to extensive immediate 
and long-term changes in the heart and reversal of functions by CRT. The long-term adaptations 
of the myocardium can be characterized as “maladaptive” because many functions continue 
to decrease over time. This also explains why CRT, unlike most pharmacological treatments, 
continues to increase its therapeutic effect over time. 
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Abstract
Aims While cardiac resynchronization therapy (CRT) clearly resynchronizes ventricular 
depolarization and thereby improves cardiac pump function in patients with dyssynchronous 
heart failure, its effect on ventricular repolarization is not entirely clear. This study explored the 
effects of CRT on repolarization by measuring T wave morphology changes after CRT, relating 
the changes to mechanical remodelling and by interpreting these results using a patient-
specific computational model.
Methods In 33 CRT recipients, electrocardiographic and echocardiographic measurements 
were performed prior to device implantation and repeatedly between 1 day and 6 months of 
CRT. Measurements were obtained both during CRT (CRT-ON) and during brief interruption 
of CRT (CRT-OFF). Twelve-lead electrocardiograms were converted to vectorcardiograms and 
QRS area and T area were calculated, along with JTc interval, T peak-to-end interval (Tp-e) and 
precordial QT dispersion. Results were interpreted using a patient-specific propagation and 
ECG model of the ventricles.
Results CRT immediately and persistently decreased QRS area and T area, whereas it increased 
JTc interval. CRT did not significantly influence Tp-e and precordial QT dispersion. During CRT-
OFF, T area, Tp-e and JTc interval increased significantly, reaching plateau levels 5-14 days after 
starting CRT. Left ventricular ejection fraction and systolic septal strain increased between 2 
weeks and 6 months of CRT. The observed changes in the T wave were largely reproduced in 
the patient-specific model when assuming an inverse relation between CRT-induced change 
in activation time and adaptation in action potential duration. The latter changes resulted in a 
reduction in dispersion of repolarization during chronic CRT as compared to acute CRT.
Conclusion CRT causes differential changes in various T wave markers that occur relatively 
fast (<2 weeks) after onset of CRT. These repolarization changes precede mechanical 
remodelling and indicate a reduction in dispersion of repolarization during longer-lasting CRT.
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Introduction
Cardiac resynchronization therapy (CRT) is an important therapy for patients with dyssynchronous 
heart failure and significantly reduces mortality and heart failure hospitalizations1. This beneficial 
effect is clearly linked to resynchronization of electrical activation, recoordination of contraction 
and accompanying improvement in pump function and cardiac reserve.
While depolarization changes after CRT have been studied in considerable detail, less is 
known about changes in repolarization caused by CRT. A few studies in both animal tissues 
and humans reported increased dispersion of repolarization during CRT or epicardial pacing2,3. 
A computer modelling study predicted increased transmural dispersion of repolarization 
directly underneath the pacing electrodes during CRT, while the effects on average transmural 
dispersion of repolarization appeared modest4.
Increased dispersion of repolarization has been linked to arrhythmias, leading to the suggestion 
that CRT may be pro-arrythmic2. However, single-centre studies did not observe a change in 
occurrence of arrhythmia after upgrade from implantable cardioverter defibrillator to CRT5,6. 
Furthermore, the arrhythmia risk was not significantly different between the CRT-ON and CRT-
OFF groups in the REVERSE trial7. Actually, the REVERSE and MADIT trials and several smaller 
studies demonstrated that CRT leads to fewer arrhythmias in CRT responders5,7–9.
A potential explanation for the discrepant findings in the small, acute studies and the larger 
clinical studies may be that repolarization is known to adapt to an altered activation sequence, 
a phenomenon that has been demonstrated by brief interruption of ventricular pacing10,11. 
This adaptation of repolarization, often referred to as “cardiac memory”, may lead to reduced 
dispersion of repolarization over time12. The time course at which this phenomenon occurs has 
not yet been studied extensively in patients receiving CRT10,13.
It was the aim of the present study to investigate the time course and extent of changes in T wave 
markers of repolarization in patients after the start of CRT. To this purpose, electrocardiographic 
(ECG) and vectorcardiographic (VCG) analyses were used, providing variables like QTc and JTc 
interval, T wave area, time interval between peak and end of the T wave (Tp-e) and precordial 
QT dispersion. Moreover, echocardiography was performed, to assess mechanical response 
to CRT and its time course relative to the electrical changes. For more detailed appreciation 
of the remodelling that underlies changes in the T wave, measurements were performed 
at multiple time points after start of CRT, both during CRT (CRT-ON) and after temporary 
interruption of CRT (CRT-OFF), the latter being used to asses “cardiac memory”. Finally, a 3D 
computational model of ventricular activation and repolarization, including “cardiac memory” 
for action potential duration (APD) was implemented to mechanistically interpret the results.
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Materials and methods
Patients
Patients referred to Maastricht University Medical Centre who were (1) 18 years of age or 
older; (2) had an indication for CRT; (3) did not have any known condition that could limit life 
expectancy to less than 6 months as of referral and (4) were capable of giving informed consent 
were asked to participate. The study conforms to the Declaration of Helsinki. The protocol was 
approved by the ethics committee of Maastricht University Medical Centre (project number 
10-2-090) and all patients gave their written informed consent to participate before inclusion.
Study protocol
Baseline 12-lead ECG was obtained at most 18 days prior to implantation of a CRT device. 
Follow-up ECGs were obtained 1 day, 5 days (range: 3-9 days), 2 weeks (8-16 days), 1 month 
(28-41 days), 3 months (2-4 months) and 6 months (6-8 months) after implantation, both 
during CRT-ON and while the CRT device was briefly switched off (CRT-OFF).
Echocardiography was performed before implantation (range: 3 months to 1 day before 
implantation) and 1 day, 2 weeks (8-19 days) and 6 months (6-8 months) after implantation. 
If no 1-day post-operative echocardiogram was available, another early post-operative 
echocardiogram was analysed (range 3-7 days). Post-operative echocardiographic 
measurements were obtained with both CRT-ON and CRT-OFF.
VCG analysis
ECGs were extracted from the MUSE Cardiology Information system (GE Healthcare, Chicago, 
US). Using custom-written MATLAB software, VCGs were synthesized from the ECGs using 
the Kors matrix and subsequently, semi-automatic analysis was performed, as described 
previously14. Maximum QRS and T vectors were defined as the maximum distances between 
the origin of the VCG loop and a point on the 3D QRS and T loops, respectively. The size and 
direction of these maximal vectors were expressed by the vector amplitude, azimuth (angle in 
the transverse plane, for QRS azimuth, the values were expressed on a full circle (360°)) and 
elevation (angle in the craniocaudal plane). Furthermore, the area under the curve of the QRS 
complex and T wave in the X, Y, and Z direction was determined by numerical integration 
from the beginning to the end of the QRS complex or T wave, respectively (Figure 3, General 
introduction). Subsequently, the three areas were summed to determine the total area of the 
QRS and T loops, using these formulas:
𝑄𝑄𝑄𝑄𝑄𝑄!"#! =	&𝑄𝑄𝑄𝑄𝑄𝑄!"#!,%& +QRS!"#!,'& +QRS!"#!,(&   and  𝑇𝑇!"#! =	&𝑇𝑇!"#!,%& + T!"#!,'& + T!"#!,(&  
 
 









𝑉𝑉* = −85	mV,  𝑉𝑉2 = 30	mV,  𝜖𝜖* = 1	ms 
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The different effects of CRT on depolarization and repolarization were further explored by 
calculating the QRS-T area ratio.
QT interval was measured automatically using the tangent method as described previously15 
and subsequently corrected for heart rate (QTc) using Fridericia’s formula, since this formula 
has been shown to be superior to Bazett’s formula16. Median Tp-e for all leads and precordial 
QT dispersion (standard deviation of start Q to precordial T ends) were determined. JTc 
was determined by subtracting QRS width from the QT interval and subsequently applying 
Fridericia’s formula.
Echocardiography
Echocardiograms were obtained using an iE33 system (Philips Medical Systems, Best, 
the Netherlands). Left ventricular end-systolic volume (LVESV) and left ventricular ejection 
fraction (LVEF) were calculated using the biplane method of disks (modified Simpson’s rule) or 
monoplane in the apical 4-chamber window if the apical 2-chamber view was of insufficient 
quality for reliable analysis. CRT response was defined as a reduction of LVESV ≥ 15% 
comparing the baseline to the 6-month CRT-ON echocardiogram.
Interventricular mechanical delay (IVMD) was defined as the time difference between opening 
of the pulmonary valve and aortic valve on the pulsed wave Doppler echocardiogram. Using 
speckle tracking analysis (QLAB version 8.1, Philips Medical Systems, Bothell, WA, USA) 
septal strain was determined, since this focusses on the ventricular wall that is visualized best 
and shows clear paradoxical motion before CRT17. Systolic septal strain (SS) was determined 
as the most negative strain value in systole. Systolic rebound stretch of the septum (SRS), a 
strong indicator of CRT response, was defined as the total amount of stretch during systole 
that occurred after initial shortening18.
In silico modelling
A previously described eikonal model with ECG simulation was adopted for simulating patient-
specific ventricular activation and depolarization19. ECG and magnetic resonance imaging 
(MRI) data of a patient, participating in an earlier study performed in Lugano, were used to 
this purpose20. The eikonal equation modelled the spread of action potential from a given 
initial set of earliest activation sites (EASs) throughout the whole active myocardium, with a 
heterogeneous, direction-dependent conduction velocity. The spatiotemporal dynamic of the 
transmembrane potential 𝑉m(𝑥, 𝑡) was modelled by setting the onset 𝜏0(𝑥) and the duration 
𝜏1(𝑥)  of an action potential (AP) template based on the formula: 
𝑄𝑄𝑄𝑄𝑄𝑄!"#! =	&𝑄𝑄𝑄𝑄𝑄𝑄!"#!,%& +QRS!"#!,'& +QRS!"#!,(&   and  𝑇𝑇!"#! =	&𝑇𝑇!"#!,%& + T!"#!,'& + T!"#!,(&  
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The following parameters were fixed for all simulations:
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The corresponding surface ECG was computed from the transmembrane potential using the 
lead field theory21. The cardiac MRI-derived and at 1-mm resolution segmented heart-torso 
anatomy included ventricles, atria, blood cavities, lungs, and skeletal muscles. Ventricular 
fibres were automatically assigned using a rule-based approach20. Intra- and extracellular 
electric conductivities and surface-to-volume ratio were set according to previous studies19. 
The baseline activation sequence, encoded in 𝜏0(𝑥), was automatically fitted, in the least-
squares sense, to the QRS complex by adapting the conduction velocity and the sites of earliest 
activation, whereas the repolarization sequence was adapted from the T wave by adjusting the 
APD 𝜏1(𝑥)  and repolarization steepness 𝜖1(𝑥)  in 6 distinct compartments: endocardium, 
mid-myocardium and epicardium of the left ventricle (LV) and the right ventricle (RV). Mid-
myocardium and epicardium respectively covered 30% and 20% of the transmural thickness. 
A 1-mm-thick endocardial layer with fast conduction was included in both the LV and RV. 
APD90 was defined as the time at which AP reached 90% of its resting potential during the 
repolarization phase. Acute CRT was simulated by biventricular pacing, with manually placed 
leads on LV epicardium and RV apex and no interventricular delay. Repolarization remodelling in 
chronic CRT was modelled by locally decreasing the APD with 60% of the difference between 
depolarization time after and prior to CRT:
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The factor x was varied between 0.5 and 0.8 to find the best match with the measured T 
wave parameters. The ECGs of 4 scenarios (baseline, acute CRT-ON, chronic CRT-ON and 
CRT-OFF) were analysed with the same workflow adopted for the clinical cohort (see above). 
Simulated baseline T area value was multiplied by a normalization factor to match the average 
baseline T area value in the patient cohort. All other simulated T and QRS area values were 
multiplied by the same factor.
Statistical analysis
Statistical analysis of the patient data was performed by fitting a mixed model (GraphPad Prism 
8, GraphPad Software, San Diego, USA). This mixed model uses a compound symmetry 
covariance matrix and is fit using Restricted Maximum Likelihood. We applied the Geisser-
Greenhouse correction to account for possible violations of the assumption of sphericity. 
For the assessment of differences between time points we performed a Bonferroni’s multiple 
comparisons test. P values ≤ 0.05 were considered statistically significant. Data are shown as 
mean ± standard deviation (SD) unless otherwise indicated.
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Results
Thirty-five patients were included in the study. One patient withdrew consent upon second 
consideration. One patient was excluded from analysis since neither ECGs nor echocardiograms 
of sufficient quality were available.
For the ECG analysis, 8 patients were excluded since too few ECGs of good quality 
were available. Therefore, ECG analysis was performed in 25 patients. In 5 patients the 
echocardiographic apical 2-chamber view was of poor quality. For this reason, the LVEF and 
LVESV measurements were performed in monoplane 4-chamber views in these 5 patients, and 
in biplane in the other 28 patients. For IVMD, all remaining 33 patients were studied. For SRS 
and SS, 32 patients were studied (1 patient excluded because of insufficient image quality).
Mean age of the 33 patients (10 women) who were included in the study was 67 ± 8 years. 
A de novo biventricular device implantation was performed in 24 patients, and 9 patients 
received an upgrade to a biventricular device because of intrinsic conduction delay (n=5) or 
right ventricular pacing (n=4). Further patient characteristics can be found in Table 1.
The RV lead was placed in an endocardial apical position in all patients. The LV lead 
(transvenously inserted in all patients but 1, in whom the lead was placed surgically) was most 
commonly implanted in the basal anterolateral (n=9), mid anterolateral (n=10) and the mid 
inferolateral (n=8) regions (Table 1).
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TABLE 1 Patient characteristics
Age (years) 67 ± 8
Female (n, %) 10 (30)
BMI (kg/m2) 27 ± 5
NYHA class  
I (n, %) 6 (18)
II (n, %) 12 (36)
III (n, %) 12 (36)
IV (n, %) 3 (9)
Ischemic cardiomyopathy (n, %) 19 (58)
AF (n, %) 8 (24)
LBBB (n,%) 28 (85)
Previous RV pacing (n, %) 4 (12)
ACE-inhibitor/ARB (n,%) 30 (91)
Beta blocker (n,%) 31 (94)
Aldosterone antagonist (n,%) 8 (24)
Loop diuretic (n,%) 21 (64)
CRT responders (n,%) 18 (60)
Percentage biventricular pacing (median (IQR)) 98.8 (97.4 - 99.4)
LV lead location (n,%)
Basal inferolateral 1 (3)
Basal anterolateral 9 (27)
Mid inferior 2 (6)
Mid inferolateral 8 (24)
Mid anterolateral 10 (30)
Apical lateral 3 (9)
Variables are shown as mean ± standard deviation or as number of patients (percentage of patients). AF = atrial 
fibrillation, ACE = angiotensin converting enzyme, ARB = angiotensin receptor blocker, BMI = body mass index, CRT 
= cardiac resynchronization therapy, IQR = interquartile range, LBBB = left bundle branch block, LV = left ventricular, 
NYHA = New York Heart Association, RV = right ventricular.
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ECG and VCG parameters
Figure 1 shows examples of ECG lead V2 of a patient during both CRT-OFF (A) and CRT-ON 
(B) at various time points. CRT-ON causes immediate amplitude reduction and narrowing of 
the QRS complex, accompanied by T wave changes. T wave amplitude increases over time 
during CRT-OFF.
FIGURE 1. Example ECGs (lead V2) during CRT-OFF (A: patient, C: simulation) and CRT-ON (B: patient, D: simulation). 
Patient ECGs were recorded at heart rates between 59 and 75 beats per minute. ECGs = electrocardiograms, further 
abbreviations as in Figure 2.
For the whole group of patients CRT caused immediate reductions in QRS area (Figure 2A), 
amplitude and duration (Table 2), indicating resynchronization of activation. During CRT-OFF, 
slight but significant increases in QRS area and amplitude were observed between 1 day and 
1 month of CRT, although QRS duration did not change (Figure 2A, Table 2).
A B
C D




FIGURE 2. Electrocardiographic and vectorcardiographic parameters during CRT-OFF (black symbols) and CRT-ON 
(red symbols). A. QRS area. B. QTc interval. C. JTc interval. D. T area. E. Tp-e. F. Precordial QT dispersion. * = p ≤ 0.05 
vs. BL; # = p ≤ 0.05 vs. 6M. BL = baseline, 1D = 1 day, 5D = 5 days, 2W = 2 weeks, 1M = 1 month, 3M = 3 months, 
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Repolarization was also profoundly affected by CRT. CRT caused a significant ~50 ms increase 
in JTc interval, whereas QTc interval only showed a small temporary increase after 1 day of 
CRT (Figure 2B and C). In contrast, T wave area (Figure 2D) and T wave amplitude (Table 
2) decreased during CRT while Tp-e and precordial QT dispersion did not show a significant 
change (Figure 2E and F). While T wave changes during CRT are most likely partly related to 
altered depolarization patterns during resynchronization, T wave changes during CRT-OFF 
are entirely due to electrical remodelling. Notably, T area, JTc, QTc and Tp-e measured during 
CRT-OFF all increased within the first two weeks of treatment, while there was no change in 
precordial QT dispersion (Figure 2, B-F).
Variables describing the direction of the QRS complex and the T wave (elevation and azimuth) 
changed within 1 day during CRT-ON and remained stable afterwards (Table 2). The spatial 
angle between QRS and T vectors also showed a quick change during CRT-ON without any 
further change (Table 2).
Echo parameters
Immediately upon start of CRT, SRS and IVMD decreased (Figure 3A and B). In contrast, it 
took approximately two weeks before LVEF, LVESV and SS (Figure 3C-E) showed a significant 
improvement. LVEF, LVESV and SS remained elevated after temporarily halting CRT, in contrast 
to IVMD and SRS (CRT-OFF, Figure 3A-E). Eighteen patients (60% out of 30 with both baseline 
and CRT-ON echocardiograms) were CRT responders (Table 1).
In silico results
The procedure to fit the patient-specific model to the baseline QRS complex identified 4 EASs 
on the RV endocardium, with 2 on the basal-septal region and 2 on the RV free wall. The best fit 
for the baseline T wave was achieved with an APD90 that was significantly shorter in epicardial 
and RV endocardial regions than in mid-myocardium and LV endocardium (200 ms vs. 260 ms 
on average; Figure 4, top panel of middle column). Simulated and recorded baseline ECGs of 
the patient correlated very well, with Pearson’s correlation r=0.96. The use of an adaptation 
factor (see methods) of 0.6 provided the largest similarity between measured and simulated 
T area during the four conditions (Table 3). This adaptation factor value also made that the 
morphology of the simulated ECGs during CRT-ON and CRT-OFF (Figure 1C and D) was 
quite well comparable to those of the patient (Figure 1A and B). Moreover, simulations and 
measurements showed minor changes in QT interval (Table 3).
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FIGURE 3. Echocardiographic parameters during CRT-OFF (black symbols) and CRT-ON (red symbols). A. Septal 
rebound stretch. B. Interventricular mechanical delay. C. Left ventricular ejection fraction. D. Left ventricular end-
systolic volume. E. Septal strain. * = p ≤ 0.05 vs. BL; # = p ≤ 0.05 vs. 6M. Abbreviations as in Figure 2.
Figure 4 illustrates the activation sequences (left panels), APDs (middle panels) and repolarization 
sequences (right panels), as calculated from the patient-specific computer model during 
baseline, acute and chronic CRT-ON and CRT-OFF. Fitting the patient’s ECG to the cardiac and 
thoracic anatomy and ECG electrode positions resulted in a typical left bundle branch block 
(LBBB)-like sequence of ventricular of activation and earlier RV than LV repolarization (Figure 
4, top row). Assuming an adaptation of APD from acute to chronic CRT based on an inverse 
relation between change in activation time and APD with a slope of 0.6 provided the same 
relative increase in T area during CRT-OFF as the mean value of the patient cohort (Figure 1, 
bottom row; Table 3). This adaptation resulted in an increase in APD in the LV lateral wall and 
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middle two panels of right column). Overall dispersion of repolarization time (expressed as the 
SD of all repolarization times in the simulation) was larger during acute CRT-ON than during 
chronic CRT-ON (41 vs. 37 ms, Figure 5 and Table 3).
The lower right panel of Figure 4 shows that during chronic CRT-OFF repolarization is 
considerably delayed in the LV free wall, which was associated with an increase in T wave area 
derived from the patient-specific simulation (from 76 to 139 mV·ms, Figure 1C and Table 3). 
Acutely, switching on CRT reduced both QRS area (from 124 to 15 mV·ms) and T area (from 





Depolarization (ms) APD (ms) Repolarization (ms)
FIGURE 4. Simulations of depolarization times (left column), action potential durations (APD, middle column) and 
repolarization times (right column), during different situations (row headers). CRT = cardiac resynchronization therapy.
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T area (mV·ms) 76 ± 27 51 ± 24 44 ± 17 131 ± 41
T area (mV·ms) 76 42 49 139
QT interval (ms) 423 ± 26 441 ± 45 428 ± 35 467 ± 24
QT interval (ms) 525 547 519 535
SD of repolarization times (ms) 46 41 37 69
Values of T area and QT interval for patients (mean ± SD) and, in italics, those obtained from simulations. BL = 
baseline, CRT = cardiac resynchronization therapy, SD = standard deviation.
347 ± 46 ms 355 ± 41 ms
350 ± 37 ms 343 ± 69 ms
FIGURE 5. Distribution of repolarization times during the different simulations. Mean ± standard deviation of 
repolarization times (ms) is indicated. BL = baseline, CRT = cardiac resynchronization therapy.
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Discussion
The main findings of the patient study are that 1) during CRT-ON, electrocardiographic 
repolarization parameters yield conflicting results and that 2) electrocardiographic measurements 
during transient CRT-OFF reveal signs of repolarization remodelling within two weeks of CRT, 
which precede mechanical remodelling. The patient-specific computer simulation indicates 
that the T wave changes during temporary interruption of chronic CRT may be explained by 
electrical remodelling processes that lead to a reduction in dispersion of repolarization during 
chronic CRT.
Assessing repolarization changes using a patient-specific computer 
simulation
A special and important feature of this study is the patient-specific computer simulation. 
The way the depolarization pattern and conduction properties of the patient were acquired 
from the 12-lead ECG and cardiac MRI has been described and validated previously19,20. The 
repolarization sequence was calculated using the same approach. The activation pattern 
during CRT was calculated using the estimated conduction properties and cardiac geometry, 
while choosing locations of the RV and LV leads that are frequently used. Finally, for assessing 
changes in repolarization during chronic CRT we assumed an inverse relation between (change 
in) activation time and APD, as demonstrated in rabbit hearts22. Such a relation has also been 
found in three rejected isolated perfused human donor hearts23 and in patients with LBBB 
prior to CRT24. The factor of 0.6 of this inverse relation was based on the fact that this factor 
provided the best match in T area changes seen in simulations and patient data for the four 
conditions studied. Note that T area and QT interval showed somewhat different behaviour, 
suggesting that the model provides a fairly unique solution.
Remodelling of repolarization
The present study demonstrates that sequential T wave measurements during CRT-OFF reveal 
changes in repolarization after 5-14 days of CRT that are not observed when measuring the 
T wave during CRT-ON. This observation may be explained by the fact that the CRT-induced 
bifocal spread of activation dominates the repolarization sequence and conceals regional 
repolarization changes. Adaptations in repolarization during longer-lasting CRT are in line with 
previous publications describing the occurrence of such changes when patients develop LBBB 
or LBBB-like activation, such as induced by RV pacing. Under those conditions the T wave is 
large immediately upon initiation of pacing or developing LBBB while it becomes smaller during 
subsequent days to weeks25,26, a time span similar to the one observed in our CRT study.
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The T wave changes during CRT-OFF are reminiscent of the phenomenon of cardiac memory, 
which is observed when returning to normal activation after a period of ventricular pacing. 
When pacing is switched off, the T wave remains abnormal despite the return of the normal 
QRS complex. In the context of CRT, interruption of pacing lets the heart return to the more 
abnormally activated baseline state (i.e. LBBB). Actually, the presence of larger T waves upon 
interrupting CRT after longer duration of treatment is quite similar to the inverse process 
observed after sudden onset of LBBB26,27.
From studies on cardiac memory it is known that the T wave changes occur by regional changes 
in APD, prolonging in early-activated regions and shortening in regions of late activation during 
the dominant activation sequence22,28. The model simulations presented in this study indicate 
that this way of adaptation may also be present in CRT patients. Importantly, this way of 
adaptation leads to a reduction in dispersion of repolarization especially in the LV wall.
The present finding that APD in the LV lateral wall increases after starting CRT may seem in 
contradiction to the findings of Chen et al.29. These investigators reported that CRT shortened 
the activation recovery interval (ARI, a surrogate measure of APD) measured within ~1 cm from 
the LV pacing site, in particular in patients responding to the therapy. However, these changes 
occurred considerably slower (between 6 weeks and 6 months of CRT) than the increase in 
T area in the present study (within 5 days and remaining constant afterwards). Therefore, we 
think that the ARI shortening represents a more local and slower process. Of note, the ARI 
shortening occurred in the same time frame as the increase in LVEF in both the Chen and the 
present study. It is possible that the negative impact of heart failure on cardiac tissue function is 
mitigated faster near the LV pacing site, because the load of that region is most pronouncedly 
reduced due to its early activation during CRT. Therefore, the ARI reduction may represent a 
decrease in APD due to decreasing severity of heart failure. In contrast, the increase in T area 
we found within 5 days of starting CRT may be caused by mechano-electrical coupling. T area, 
being a more global measure of repolarization, may miss the local APD changes as measured 
by a local electrogram by Chen et al.
The present study does not allow speculation about the molecular mechanisms involved in 
repolarization remodelling, but it suffices to refer to the extensive work of the group of Dr. 
Michael Rosen, who showed involvement of stretch-induced local release of angiotensin II, 
modulation of transcription factors and changes in IKr and ICa,L11. Regional differences in stretch, 
coinciding with abnormal activation, were shown to be a crucial factor for inducing cardiac 
memory30. Experimentally, Sosunov et al. showed that reduction of cardiac mechanics by 
unloading the LV or blocking excitation-contraction coupling attenuated the development of 
cardiac memory30. Based on this information Kuijpers et al. proposed that T wave memory 
is mediated by mechano-electrical feedback, aiming at homogenization of myocardial work. 
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Using computer simulations they found that such mechano-electrical coupling leads to a 
prolonged APD near the LV pacing region and a lower overall dispersion of repolarization12, 
which is in line with the results of the present study.
T wave changes during CRT
The present study indicates that the apparently contradicting changes in T area and JTc during 
CRT may be explained by the different aspects of repolarization measured by these parameters. 
JTc reflects the mean duration of the ventricular action potential, after all it is calculated as the 
difference between QT and QRS interval. T area, on the other hand, presumably increases 
with longer JTc as well as with a more unidirectional repolarization (i.e. less cancellation of 
repolarization forces).
The three-dimensional simulation data illustrate that during acute CRT-ON there is more 
cancellation of repolarization than during LBBB, especially in the LV (fitting with a reduction 
in T area), whereas the difference between earliest and latest repolarized region does not 
decrease (fitting with a small increase in QTc, observed in the patients). The histograms of 
repolarization times in the simulations (Figure 5) clarify these ideas by showing a decrease in 
SD of repolarization times but an increase in the time between earliest and latest repolarization 
during acute CRT-ON compared to baseline.
Clearly, all ECG and VCG measures of dispersion of repolarization describe only part of the 
total dispersion. T wave area is an integral measure, presumably describing mainly overall 
dispersion of repolarization31. As mentioned above, QTc and JTc primarily indicate the 
maximum repolarization time2. Precordial QT dispersion has been suggested to provide a more 
detailed impression of the dispersion of repolarization, although T vector orientation relative 
to the different leads has been proposed as the underlying mechanism of this phenomenon, 
too32. Tp-e has been announced as a marker of transmural dispersion of repolarization, although 
there is also considerable dispute about this idea3,4,33. To complicate the picture even more, 
epicardial LV pacing can be expected to increase the transmural dispersion of repolarization 
directly underneath the pacing electrode, but this difference may be small in regions more 
remote from the pacing site4. To summarize, ECG and VCG measures of repolarization each 
provide a limited impression of this process. The present study does indicate that the clearest 
impression of changes in repolarization in CRT patients can be obtained by briefly interrupting 
CRT.
Remodelling in activation?
Interestingly, in our study, QRS area and QRS amplitude increased slightly (by ~15%) but 
significantly during CRT-OFF during the first month of CRT. The data in the present study do 
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not provide a direct explanation of this unexpected finding. However, several animal studies 
have demonstrated that dyssynchrony can cause abnormal distribution of connexin 43 (Cx43), 
including lower expression levels and altered subcellular localization in the lateral wall of the 
LV34,35. Cx43 relocalization has also been observed after stretching cultured cardiomyocytes36. 
Since dyssynchrony causes major local mechanical changes, these findings together support 
the idea that dyssynchrony-induced mechanical derangements may affect myocardial impulse 
conduction in the heart. Since cellular uncoupling may lead to lower QRS amplitudes37, it may 
be speculated that an increase in Cx43 expression and/or more polarized Cx43 localization 
may lead to more uniform (but not overall faster) depolarization, resulting in the increase in QRS 
area after CRT. However, further studies are needed to corroborate these findings and to better 
understand this (transient) phenomenon.
Limitations
This study has several limitations. First of all, the number of patients that was studied was 
small. Secondly, the observational nature of the study implied that patient treatment was 
not protocolled but was adjusted as required, and e.g. device settings were changed when 
needed. ECG measurements were obtained at more time points than echocardiographic 
measurements. However, the two-week measurements were performed for both variables 
and LVEF and SS continued to increase towards 6 months, whereas repolarization markers 
levelled off at two weeks.
Future directions
The present study describes the T wave changes after various durations of CRT. The small 
study size precluded investigating the relation of these T wave changes with arrhythmia risk. 
The use of ECG and VCG provided only relatively global information on cardiac activation 
and repolarization. Detailed cardiac mapping (e.g. non-invasive non-contact (ECG imaging) 
or invasive contact mapping) may provide more in-depth information about the regional 
repolarization changes after CRT and may solve the question which of the markers of dispersion 
of repolarization may be most relevant for predicting arrhythmias.
Conclusions
CRT causes differential changes in various T wave markers that occur relatively fast (<2 weeks) 
after onset of CRT. These changes precede mechanical remodelling and indicate a reduction 
in dispersion of repolarization during longer-lasting CRT. Our electrocardiographic findings are 
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corroborated by computer modelling, using a patient-specific model. Lengthening of APDs in 
zones of early activation and shortening of APDs in zones of late activation in the model yielded 
T area changes that were quite similar to those observed in patients.
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Abstract
Background The beneficial effects of cardiac resynchronization therapy (CRT) on cardiac 
function are well established. However, less is known about the connection between contractile 
and electrical remodelling. Previously we showed that the change in T area after temporarily 
interrupting CRT is an indicator of electrical remodelling of repolarization. The aim of this study 
is to investigate the link between T wave changes and 1) echocardiographic response following 
CRT and 2) occurrence of arrhythmias following CRT.
Methods In 76 patients, electrocardiograms (ECGs) were recorded prior to CRT implantation 
(baseline, BL) and after 6-12 months of treatment (both during CRT (CRT-ON) and during 
brief interruption of CRT (CRT-OFF)). Vectorcardiograms (VCGs) were synthesized from the 
12-lead ECGs. JTc and QTc intervals, T peak-to-end interval (Tp-e), precordial QT dispersion 
and VCG-derived T area were used as measures of repolarization. Echocardiograms, 24-hour 
Holter recordings (at BL and 6 months) and device readout data on arrhythmias (2 weeks and 
6 months after implantation) were collected.
Results The cohort was divided into subgroups with a T area change smaller (LOW) and larger 
(HIGH) than the median T area change measured during CRT-OFF. There were no significant 
differences in baseline QRS duration, QRS area or T area between these subgroups. Patients 
in the HIGH subgroup showed a larger increase in left ventricular ejection fraction than those in 
the LOW subgroup (11 ± 8 vs. 6 ± 6 % respectively, p ≤ 0.05). QTc, JTc, Tp-e and T wave vector 
angles were not significantly different between the subgroups. Arrhythmia incidence was low 
and did not differ between the subgroups.
Conclusions Repolarization remodelling, as indicated by a large T area change during CRT-
OFF at follow-up, is associated with better echocardiographically measured response to CRT. 
Consequences of these T area changes for arrhythmia incidence need to be investigated in 
larger studies.
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Introduction
Cardiac resynchronization therapy (CRT) is an effective treatment for dyssynchronous heart 
failure, improving cardiac pump function as well as survival1. A short-term study in patients, 
however, suggests a potential pro-arrhythmic effect of CRT through increased dispersion of 
repolarization2. A similar mechanism was also observed in animal tissues during epicardial 
pacing3. On the other hand, several other studies in patients, including clinical trials, demonstrate 
that arrhythmia incidence following CRT may decrease in responders, while it may increase in 
non-responders4,5. The difference in arrhythmia risk between responders and non-responders 
suggests a link between electrical and mechanical remodelling following CRT.
We have previously investigated electrical remodelling following CRT6, in particular changes 
in repolarization dispersion (chapter 3). In those studies, we demonstrated that changes in T 
wave area when the CRT device is briefly switched off (indicative of repolarization remodelling) 
already occur within the first days to weeks of treatment. The reason that T wave area may be 
a good method to study repolarization remodelling is that it depends on both the duration and 
homogeneity of repolarization7.
Computer modelling data from the previous study (chapter 3) indicated that repolarization 
remodelling reduces the inhomogeneity of repolarization. For this reason, and because of the 
link between electrical and mechanical remodelling described earlier, we hypothesize that 
extensive repolarization remodelling is associated with a larger improvement in left ventricular 
ejection fraction (LVEF) and fewer arrhythmias.
The aim of the present study is to explore the potential link between repolarization remodelling 
and 1) LVEF change and 2) ventricular arrhythmia incidence after CRT. To this end, T area 
and other electrocardiographic (ECG) and vectorcardiographic (VCG) parameters were 
assessed in patients, prior to device implantation and after 6-12 months of CRT. At follow-
up, measurements were performed both while CRT was on (CRT-ON) and when CRT was 
briefly switched off (CRT-OFF). Additionally, information about arrhythmias (24-hour Holter 
recordings, device readouts) and CRT response (echocardiography) was obtained. Patients 
were stratified according to T area change (indicative of the amount of electrical remodelling) 
between baseline and the CRT-OFF measurements, and parameters were compared between 
those who had a small T area change (LOW) and those who had a large T area change (HIGH).
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Materials and methods
Patients
This study included consecutive patients, referred to the Maastricht University Medical Centre 
for possible CRT implantation. Patients who were (1) 18 years of age or older; (2) had an 
indication for CRT; (3) did not have any known condition that could limit life expectancy to less 
than 6 months as of referral and (4) were capable of giving informed consent were asked to 
participate. The study conforms to the Declaration of Helsinki. The protocol was approved by 
the ethics committee of Maastricht University Medical Centre (project number 10-2-090) and 
all patients gave written informed consent to participate before inclusion.
Study protocol
Baseline 12-lead ECGs were obtained within ~one year prior to implantation of a CRT device. 
Follow-up ECGs were recorded 6 (range: 3-13) months after implantation, both during CRT-
ON and while the CRT device was briefly switched off (CRT-OFF). Echocardiography was 
performed before implantation and 6 (5-10) months after implantation. Holter recordings were 
obtained both prior to starting CRT and after 6 (5-8) months. CRT device readouts were 
performed after 2 (1-3) weeks and 6 (4-9) months of therapy.
VCG analysis
ECGs were extracted from the MUSE Cardiology Information system (GE Healthcare, Chicago, 
US). Using custom-written Matlab software, ECGs were transformed to VCGs utilizing the 
Kors matrix and semi-automatic analysis was performed as described previously8. Maximum 
QRS and T vectors were defined as the maximum distances between the origin of the VCG 
loop and a point on the 3D QRS and T loops, respectively. The size and direction of the 
maximum vectors were expressed by the vector amplitude, azimuth (angle in the transverse 
plane, 0 is at the left arm; for QRS azimuth, the values were expressed on a full circle (360°)) 
and elevation (angle in the craniocaudal plane). Furthermore, the area under the curve of the 
QRS complex and T wave in the X, Y, and Z direction was determined by numerical integration 
from the beginning to the end of the QRS complex or T wave, respectively (Figure 3, General 
introduction). Subsequently, the total areas of the QRS and T loops were determined using 
these formulas:
𝑄𝑄𝑄𝑄𝑄𝑄!"#! =	&𝑄𝑄𝑄𝑄𝑄𝑄!"#!,%& +QRS!"#!,'& +QRS!"#!,(&   and  𝑇𝑇!"#! =	&𝑇𝑇!"#!,%& + T!"#!,'& + T!"#!,(&  
 
The different effects of CRT on depolarization and repolarization were further explored by 
calculating the QRS-T area ratio.
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QT interval was measured automatically using the tangent method as described previously9 
and subsequently corrected for heart rate (QTc) using Fridericia’s formula, since this formula 
has been shown to be superior to Bazett’s formula10. Median T peak-to-end interval (Tp-e) for 
all leads as well as precordial QT dispersion (standard deviation of start Q to precordial T ends) 
were determined. The JTc interval was determined by subtracting QRS duration from the QT 
interval and subsequently applying Fridericia’s formula.
Echocardiography
Echocardiograms were obtained using an iE33 system (Philips Medical Systems, Best, the 
Netherlands). Left ventricular end-systolic and diastolic volumes (LVESV and LVEDV) were 
calculated using the biplane method of disks (modified Simpson’s rule), or monoplane in the 
apical 4-chamber window if the apical 2-chamber view was of insufficient quality for reliable 
analysis. CRT response was defined as an absolute increase of LVEF ≥5%, after 6 months of 
CRT compared to baseline.
Statistical analysis
All analyses were carried out in GraphPad Prism 8 (GraphPad Software, San Diego, USA).
For the whole cohort, differences between baseline/CRT-OFF/CRT-ON were evaluated using 
a one-way repeated measures analysis of variance (ANOVA), followed by Bonferroni’s multiple 
comparisons test. Parameters with only baseline and one follow-up value (e.g. LVEF) were 
assessed using a paired t-test.
Differences between and within the HIGH and LOW subgroups were evaluated using two-way 
mixed effects ANOVA followed by Bonferroni’s multiple comparisons test. For LVEF and LVESV 
change and patient characteristics that are continuous variables (e.g. age), an unpaired t-test 
was employed.
Categorical variables were compared using Fisher’s exact test, except for left ventricular 
(LV) lead locations, due to low patient numbers in multiple categories. For New York Heart 
Association class comparison between the two subgroups, class I & II and III & IV were 
combined to increase the number of patients per category.
Where appropriate, we applied the Geisser-Greenhouse correction during ANOVA to account 
for possible violations of the assumption of sphericity. P values ≤ 0.05 were considered 
statistically significant. Data are shown as mean ± standard deviation or median (interquartile 
range).
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Results
In total, for 80 patients a complete set of baseline, follow-up CRT-ON and follow-up CRT-
OFF ECGs was obtained. Four patients were excluded because of different QRS morphology 
during intrinsic conduction at baseline and at follow-up (due to e.g. intermittent left bundle 
branch block (LBBB)).
In 15 patients only four-chamber apical views of good quality could be obtained during 
echocardiography. Therefore, monoplane LV volumes and LVEF were determined for these 
patients. Echocardiograms were not obtained in 5 patients.
Paired Holter recordings were available for 18 patients in the LOW subgroup and 22 patients 
in the HIGH subgroup. Device readouts regarding ventricular arrhythmias (N = 31 LOW, N = 27 
HIGH) and premature ventricular contraction (PVC) runs (N = 12 LOW, N = 18 HIGH) were also 
obtained. A ventricular run was defined as 3 or more consecutive PVCs.
Patients were 67 ± 9 years old and 33 (43%) were female. Heart failure aetiology was ischemic 
in 40 patients (53%). LBBB was present in 53 patients (70%) and six patients received an 
upgrade because of previous right ventricular (RV) pacing. 14 patients (18%) had atrial 
fibrillation. More detailed patient characteristics are presented in Table 1.
The LV lead was most commonly placed in an anterolateral (n = 37) or inferolateral (n = 25) 
position. The RV lead was placed in the apex in almost all patients, except for one patient in 
whom the lead was inserted in a septal position.
Entire patient cohort
LVEF significantly increased from 25 ± 7 % at baseline to 34 ± 10 % at follow-up (Figure 1A). 
Forty-eight patients (68%) were classified as echocardiographic responders. LVESV decreased 
significantly, from 140 ± 47 ml at baseline to 105 ± 46 ml at follow-up.
QRS duration, QRS area and QRS amplitude all decreased significantly during CRT-ON 
compared to baseline, while QRS area and amplitude decreased slightly but significantly 
during CRT-OFF (Figure 1B and Table 2).
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TABLE 1 Patient characteristics
All patients (n = 76) LOW (n = 38) HIGH (n = 38)
Age (years) 67 ± 9 67 ± 9 66 ± 9
Female (n, %) 33 (43) 18 (47) 15 (39)
BMI (kg/m2) 26 ± 5 26 ± 6 27 ± 5
NYHA class 
I (n, %) 6 (8) 0 (0) 6 (16)
II (n, %) 45 (59) 23 (61) 22 (58)
III (n, %) 24 (32) 15 (39) 9 (24)
IV (n, %) 1 (1) 0 (0) 1 (3)
Ischemic cardiomyopathy 
(n, %)
40 (53) 23 (61) 17 (45)
AF (n, %) 14 (18) 10 (26) 4 (11)
LBBB (n,%) 53 (70) 24 (63) 29 (76)
Previous RV pacing (n, %) 6 (8) 3 (8) 3 (8)
ACE-inhibitor/ARB (n,%) 69 (91) 37 (97) 32 (84)
Beta blocker (n,%) 71 (93) 35 (92) 36 (95)
Aldosterone antagonist (n,%) 22 (29) 12 (32) 10 (26)
Loop diuretic (n,%) 47 (62) 30 (79) 17 (45)#
CRT Responders (n,%) 48 (68) 23 (64) 25 (71)
Biventricular pacing 
(%, median (IQR))
99.1 (97.5 – 99.9) 99.1 (97.0 – 99.9) 99.2 (98.1 – 99.7)
LV lead location (n,%)
Basal anterior 1 (1) 0 (0) 1 (3)
Basal inferolateral 8 (11) 6 (16) 2 (5)
Basal anterolateral 15 (20) 7 (18) 8 (21)
Mid inferior 4 (5) 3 (8) 1 (3)
Mid inferolateral 17 (22) 7 (18) 10 (26)
Mid anterolateral 22 (29) 13 (34) 9 (24)
Apical lateral 9 (12) 2 (5) 7 (18)
Patient characteristics for the entire patient cohort and for the subgroups of patients with T area change after 6 
months during CRT-OFF that was smaller (LOW) or larger than the median (HIGH). Variables are shown as mean ± 
standard deviation or as number of patients (percentage of patients). AF = atrial fibrillation, ACE = angiotensin 
converting enzyme, ARB = angiotensin receptor blocker, BMI = body mass index, CRT = cardiac resynchronization 
therapy, IQR = interquartile range, LBBB = left bundle branch block, LV = left ventricular, NYHA = New York Heart 
Association, RV = right ventricular. # = significant difference between the LOW and HIGH subgroups.
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Compared to baseline, T area and T amplitude decreased significantly during CRT-ON and 
increased significantly during CRT-OFF (Figure 1C, Table 2). The change in T area between 
baseline and CRT-OFF did not differ between echocardiographic responders and non-
responders (48.0 ± 47.5 vs 41.8 ± 22.9 mV·ms, p > 0.05). From baseline, QTc interval only 
increased significantly during CRT-OFF, whereas JTc interval increased significantly during both 
CRT-ON and CRT-OFF (Table 2). Compared to baseline, Tp-e increased during CRT-OFF while 
precordial QT dispersion did not change compared to baseline in either condition (Table 2).
Vectorcardiographic azimuth and elevation of QRS complex and T wave hardly changed 
during CRT-OFF compared to baseline (Table 2). During CRT-ON the main QRS azimuth and 
elevation changed significantly, denoting a move upwards and to the right, while the main T 
axis moved downwards and to the left, causing a small but significant reduction in spatial peak 
QRS-T angle (Table 2).
Device readouts showed only a small number of ventricular arrhythmias (none in most 
patients), both after 2 weeks and 6 months of CRT. Data from devices and Holter recordings 
demonstrated that the number of PVC runs per hour did not differ between the early time point 
(baseline or two weeks) and the late time point (6 months) (device: 0.7 (0.1–2.8) at 2 weeks 
vs. 0.5 (0.0–2.2) at 6 months, p > 0.05; Holter 0.0 (0.0-0.1) at baseline vs. 0.1 (0.0-0.3) at 6 
months, p > 0.05).
Stratification by T area change
The median increase in T area between baseline and the follow-up CRT-OFF measurement was 
41 mV·ms. Patient characteristics were comparable between the subgroups with a change in 
T area less than and more than 41 mV·ms (LOW and HIGH subgroups, respectively), except 
for the larger proportion of patients receiving a loop diuretic in the LOW subgroup (Table 1). 
Baseline VCG parameters, LVEF and LVESV (LOW 143 ± 49 vs. HIGH 136 ± 46 ml, p > 0.05) 
were also comparable (Figure 2A-D, Figure 3A, Table 3).
Patients in the HIGH subgroup had a significantly larger T area during CRT-OFF than patients 
in the LOW subgroup, despite similar T area during CRT-ON (Figure 2A). In the LOW subgroup 
T amplitude did not increase significantly during CRT-OFF as compared to baseline, while for 
the HIGH subgroup, an increase occurred (Table 3).
QRS area and amplitude remained unchanged between baseline and CRT-OFF in the HIGH 
subgroup, but in the LOW subgroup, a significant decrease was observed (Figure 2B, Table 
3). Together with the slightly lower baseline QRS area in the LOW subgroup this created a 
significant difference in QRS area (Figure 2B) and amplitude (Table 3) between the subgroups 
during CRT-OFF. This difference was not visible during CRT-ON.
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TABLE 2 ECG and VCG variables for the entire patient cohort 
BL OFF ON
Heart rate (bpm) 71 ± 12 65 ± 11* 67 ± 10*
QRS duration (ms) 181 ± 24 179 ± 25 154 ± 24*
QRS amplitude (mV) 1.7 ± 0.5 1.6 ± 0.5* 1.1 ± 0.4*
T amplitude (mV) 0.5 ± 0.2 0.7 ± 0.3* 0.3 ± 0.1*
QRS/T Area ratio 1.7 ± 0.7 1 ± 0.3* 2.1 ± 1.9
Tp-e (ms) 81 ± 21 96 ± 16* 76 ± 16
Precordial QT dispersion (ms) 19 ± 12 17 ± 9 18 ± 11
QTc (ms) 440 ± 34 467 ± 32* 440 ± 31
JTc (ms) 250 ± 33 284 ± 25* 281 ± 29*
Azimuth QRS (degrees) 294 ± 24 282 ± 39* 215 ± 61*
Elevation QRS (degrees) 85 ± 24 88 ± 24* 120 ± 31*
Azimuth T (degrees) 100 ± 45 102 ± 61 18 ± 73*
Elevation T (degrees) 92 ± 23 94 ± 24 57 ± 30*
Spatial peak QRS-T angle (degrees) 160 ± 17 159 ± 13 140 ± 33*
Values are shown as mean ± standard deviation. * = p ≤ 0.05 vs. BL. Tp-e = T peak-to-end interval. For further 
abbreviations see legend Figure 2.
FIGURE 1. A. LVEF at baseline and during CRT-ON at follow-up. B. QRS area during CRT-OFF (black symbols) and 
CRT-ON (red symbol). C. T area during CRT-OFF and CRT-ON. * = p ≤ 0.05 vs. BL. BL = baseline, CRT = cardiac 
resynchronization therapy, FU = six-month follow-up, LVEF = left ventricular ejection fraction.
A B C
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FIGURE 2. VCG and ECG parameters during CRT-OFF and CRT-ON in the patient subgroups with T area change 
smaller than median (LOW, white bars) and T area change larger than median (HIGH, blue bars). A. T area. B. QRS 
area. C. QTc interval. D. JTc interval. # = p ≤ 0.05 for LOW vs. HIGH in the indicated measurement; * = p ≤ 0.05 vs. BL. 
BL = baseline, CRT = cardiac resynchronization therapy, ECG = electrocardiographic, VCG = vectorcardiographic, 
OFF and ON denote CRT-OFF and CRT-ON, respectively, at six-month follow-up.
Between the subgroups, no significant differences in QRS duration, QTc, JTc, Tp-e and precordial 
QT dispersion were observed at any time point (Figure 2C and D, Table 3). QRS and T vector 
angles were also comparable for both subgroups at all time points, although QRS-T angle 
decreased significantly between baseline and CRT-ON only in the HIGH subgroup (Table 3).
LVEF values were not significantly different between the two subgroups at baseline, but at 
follow-up, patients in the HIGH subgroup had a significantly higher LVEF than patients in the 
LOW subgroup (Figure 3A). This difference was also reflected in the significantly larger increase 
in LVEF in the HIGH subgroup (Figure 3B). For LVESV, no significant differences were observed 
between the LOW and the HIGH subgroups at follow-up (111 ± 53 vs. 98 ± 38 ml respectively, 
p > 0.05). Change in LVESV between baseline and follow-up measurements did not differ 




Relation between repolarization remodelling and response to cardiac resynchronization therapy | 87
4
TABLE 3 ECG and VCG variables stratified according to T area change
BL LOW BL HIGH OFF LOW OFF HIGH ON LOW ON HIGH
Heart rate (bpm) 74 ± 11 68 ± 13 67 ± 13* 63 ± 9 69 ± 9* 64 ± 9#
QRS duration (ms) 178 ± 25 184 ± 22 176 ± 27 182 ± 24 154 ± 29* 154 ± 19*
QRS amplitude (mV) 1.7 ± 0.5 1.7 ± 0.5 1.4 ± 0.4* 1.8 ± 0.4# 1 ± 0.4* 1.1 ± 0.5*
T amplitude (mV) 0.5 ± 0.3 0.5 ± 0.2 0.6 ± 0.2 0.9 ± 0.2*# 0.3 ± 0.2* 0.3 ± 0.1*
QRS/T Area ratio 1.6 ± 0.5 1.9 ± 0.8 1 ± 0.3* 0.9 ± 0.2* 1.9 ± 1.9 2.2 ± 1.8
Tp-e (ms) 80 ± 14 81 ± 26 93 ± 16* 99 ± 16* 79 ± 15 73 ± 17
Precordial QT dispersion (ms) 18 ± 9 20 ± 15 16 ± 9 17 ± 10 17 ± 10 19 ± 11
Azimuth QRS (degrees) 288 ± 27 301 ± 20 275 ± 51 289 ± 19* 210 ± 73* 220 ± 46*
Elevation QRS (degrees) 89 ± 26 81 ± 21 93 ± 28 83 ± 18 120 ± 36* 120 ± 25*
Azimuth T (degrees) 91 ± 49 108 ± 40 92 ± 69 111 ± 51 13 ± 73* 24 ± 73*
Elevation T (degrees) 88 ± 24 97 ± 21 90 ± 25 98 ± 22 54 ± 31* 61 ± 29*
Spatial peak QRS-T 
angle (degrees)
156 ± 21 163 ± 11 159 ± 14 160 ± 13 146 ± 34 134 ± 31*
Values are shown as mean ± standard deviation. LOW denotes patients with T area change smaller than median, 
HIGH denotes patients with T area change larger than median. # = p ≤ 0.05 for LOW vs. HIGH in the indicated 
measurement; * = p ≤ 0.05 vs. BL. Tp-e = T peak-to-end interval. For further abbreviations see legend Figure 2.
FIGURE 3. A. LVEF in the patient subgroups with T area change smaller than median (LOW, white bars) and T area 
change larger than median (HIGH, blue bars). B. LVEF change between baseline and follow-up in the two subgroups. 
# = p ≤ 0.05 for LOW vs. HIGH in the indicated measurement; * = p ≤ 0.05 vs. BL. BL = baseline, FU = six-month 
follow-up, LVEF = left ventricular ejection fraction.
A B
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Neither the number of PVC runs per hour (Holter baseline LOW 0.0 (0.0 – 0.1), baseline HIGH 
0.0 (0.0 – 0.1), 6 months LOW 0.1 (0.0 – 0.2), 6 months HIGH 0.1 (0.0 – 0.3); device 2 weeks 
LOW 0.7 (0.2 – 1.5), 2 weeks HIGH 0.7 (0.1 – 7.2), 6 months LOW 0.7 (0.0 - 2.0), 6 months 
HIGH 0.4 (0.0 – 2.2)) nor the number of ventricular arrhythmia episodes differed between the 
two subgroups at either baseline, 2 weeks or 6 months.
When we stratified the patients by echocardiographic response to CRT, we did not observe a 
difference in PVC runs from Holter or device between these two subgroups.
Discussion
The main findings of our study are that repolarization remodelling after CRT (characterized by 
a larger increase in T area) is associated with echocardiographically measured response and 
that in this cohort (with few arrhythmias) no association with the risk of ventricular arrhythmia 
following CRT was observed.
Ejection fraction and repolarization change
While T area changes after CRT have been reported before6, to the best of our knowledge 
our study is the first to assess the link between T area change and echocardiographically 
measured CRT response.
The exact mechanisms behind the link between T wave changes and CRT response cannot 
be derived from this study, although in general it can be stated that hearts that show adaptive 
capacity with regard to contraction also do so with regard to electrophysiology4,5. While 
contractile and electrical remodelling may not be based on a common mechanism, it is 
interesting to note that both computer simulation studies11 and animal experiments12 have 
indicated a possible link between calcium currents and cardiac remodelling during CRT. Calcium 
currents play an important role in both repolarization and contraction. The increase in T area 
that we observe during CRT-OFF (chapter 3) seems to be in line with computer simulations 
that assume a kind of mechano-electrical feedback: weakening of contraction, as is the case 
in early activated regions, is counteracted by an increase in calcium influx11. This increased 
influx also causes action potential duration (APD) prolongation, while the opposite phenomena 
occur in late activated regions11. It is therefore tempting to speculate that these phenomena 
may at least contribute to the link we found between T area change and ejection fraction 
increase. Studies in patients, however, have both shown prolongation13 and shortening14 of 
the activation recovery interval (ARI, a surrogate for APD) in zones of early activation during 
RV pacing or CRT. In the latter study, CRT responders showed a reduction of ARI close to 
the pacing site, while non-responders showed an increase14. The time scale at which these 
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changes occurred (weeks to months)14, however, is considerably longer than the time scale at 
which T wave changes after CRT have been reported (days to weeks, chapter 3), meaning 
that this may represent a different mechanism.
Furthermore, other mechanisms (e.g. asymmetric hypertrophy, which develops during LBBB 
and disappears during CRT15,16) may also affect T wave amplitude and may thus play a role17. 
Summarizing, the exact mechanisms are still unclear, but the link between electrical and 
mechanical remodelling has been demonstrated from a variety of angles.
Differences in de- and repolarization parameters
Of all repolarization parameters we studied, only T area and amplitude were significantly 
different between the LOW and the HIGH patient subgroups, and only during CRT-OFF. These 
observations are in line with an earlier study by Lellouche et al. that showed that QTc measured 
after one year of CRT did not differ between responders and non-responders18. This study, 
however, found that Tp-e was shorter in responders18. This finding is corroborated by another 
study, demonstrating (during CRT-ON) a shorter Tp-e  in CRT responders compared to non-
responders after 3 months of CRT19. In our study, Tp-e was not significantly changed during 
CRT-ON, not even in the HIGH subgroup, that showed a better echocardiographic response 
than the LOW subgroup.
On the other hand, Tp-e significantly increased during CRT-OFF, just like T area. This indicates 
that turning CRT off may be a relevant provocation test to unravel changes in repolarization 
after CRT. This also holds true for the increases in QTc and JTc.
Interestingly, during CRT-OFF measurements not only T area, but also QRS area and amplitude 
were different between the LOW and HIGH subgroups. In particular, QRS area and amplitude 
decreased significantly in the LOW subgroup, which showed a smaller increase in LVEF 
than the HIGH subgroup. This observation suggests changes in ventricular activation over 
the six-month follow-up period, unveiled by the CRT-OFF procedure. Because QRS duration 
did not change significantly during CRT-OFF, total activation is not likely to have changed. 
The reduction in QRS amplitude in the LOW subgroup indicates a reduction in unopposed 
electrical forces, possibly caused by a more irregular pattern of conduction. Potential causes 
of the latter may be negative tissue remodelling (e.g. due to cellular uncoupling or the loss of 
viable myocardium)20,21, which may relate to the poorer response to CRT in this subgroup.
Arrhythmia risk
A link between echocardiographic CRT response and ventricular arrhythmia incidence has 
been found in several studies, with responders generally showing a lower arrhythmia risk4,5,19,22–
24. This indirectly suggests that tissue remodelling and arrhythmia risk are inversely related. 
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In our study, however, no difference was found in arrhythmia incidence, neither between the 
LOW and HIGH subgroups nor between responders and non-responders. The most important 
explanation for this observation is the relative rarity of arrhythmias in our cohort, thus lowering 
the statistical power to find any significant differences.
Out of 58 patients for whom device data was available, 1 patient experienced ventricular 
fibrillation and 5 experienced ventricular tachycardia. This incidence is relatively comparable 
to the findings of the REVERSE trial (14% of patients experienced any type of arrhythmia)24, 
but somewhat lower than in the study by Itoh (20% of patients experienced some kind of 
arrhythmia)19. Possibly, the differences in NYHA class between the studies played a role: in our 
study, the majority of patients was in NYHA class I and II, while in the study by Itoh, patients 
were in NYHA class III or IV.
Based on the link between repolarization dispersion and arrhythmias, we also investigated 
whether there was a connection between the latter and T area change. However, even when 
comparing the 5 patients with the largest number of ventricular runs per hour on Holter after 6 
months with the other patients for whom Holters were available, no differences in T area were 
seen at any of the time points (data not shown).
In conclusion, although the majority of patients in our cohort show a significant increase in T 
area when temporarily turning off CRT (indicating changes in ventricular repolarization, see 
also chapter 3) these repolarization changes may not directly relate to the (rare) occurrence 
of arrhythmias.
Limitations
This study has several limitations. Firstly, the sample size was relatively small. This particularly 
impacts the evaluation of the data of the infrequent ventricular arrhythmias. The observational 
nature of the study implies that e.g. device settings and medications were adjusted as judged 
necessary during the study period. Further studies are required to determine the optimum 
parameter to identify post-CRT electrical remodelling.
Conclusions
A larger degree of repolarization remodelling may be linked to a stronger echocardiographically 
measured response to CRT. This effect occurred during a virtual absence of arrhythmias.
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Abstract
Background Cardiac resynchronization therapy (CRT) has well-described beneficial effects on 
dyssynchronous heart failure and may also cause a reduction in functional mitral regurgitation 
(MR). However, it is not yet known whether CRT may still be beneficial if structural MR is present. 
Moreover, it is unclear which pacing mode would be most advantageous in this scenario.
Methods In 8 dogs, structural MR was induced through destruction of the chordae tendineae 
and 4 weeks later left bundle branch block (LBBB) was induced through radiofrequency 
ablation (MR+LBBB). Eleven dogs with only LBBB served as the control group. Over time, 
echocardiographic and haemodynamic measurements were performed. After 16 weeks of 
LBBB haemodynamic measurements were performed during three pacing modes: biventricular 
(BiVbest) pacing, left ventricular (LV) pacing with a short atrioventricular (AV) delay (LVshort) and LV 
pacing with an AV delay aimed at fusion with intrinsic activation (LVfusion).
Results LV end-diastolic volume was significantly larger in MR+LBBB dogs than in the LBBB 
group, while LV end-diastolic pressure also tended to be higher in the former. All pacing modes 
significantly increased the maximum rate of LV pressure rise (LVdP/dtmax) in the LBBB dogs. 
In the MR+LBBB group BiVbest tended to increase in LVdP/dtmax (p=0.14) and significantly 
reduced LV end-diastolic pressure (LVPed).
Conclusions Despite the presence of structural MR in the MR+LBBB animals, CRT can 
improve ventricular pump function in LBBB hearts, as evidenced by a moderate increase in 
LVdP/dtmax, and a significant decrease in LVPed. In this animal model of MR+LBBB the various 
pacing modes (BiV, LVshort or LVfusion) result in comparable haemodynamic effects.
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Introduction
Two types of functional mitral regurgitation (MR) have been described in patients with heart 
failure: proportionate and disproportionate, reflecting whether the relation between left 
ventricular end-diastolic volume (LVEDV) and the severity of MR is linear or not1. Proportionate 
MR is caused by dilatation of the left ventricle (LV) with dislocation of the papillary muscles and 
chordae tendineae, plus dilatation of the mitral annulus1. This combination impairs coaptation 
of the mitral valve leaflets1. In disproportionate MR the amount of regurgitation is larger than 
what would be expected based on LVEDV, suggesting other contributing factors like mitral 
valve leaflet tethering due to dyssynchronous contraction of the papillary muscles in patients 
with left bundle branch block (LBBB)1.
Cardiac resynchronization therapy (CRT) may beneficially impact MR in ventricular dyssynchrony 
through several mechanisms2. Resynchronization of contraction leads to faster build-up of 
pressure3, while resynchronization of the papillary muscles may result in improved positioning 
of the valve leaflets4, both of which improve valve closure. Moreover, CRT may reduce mitral 
orifice size5 and atrioventricular (AV) dyssynchrony2,6, thus further ameliorating MR. These 
effects can be observed acutely3, but also long-term7, with reverse remodelling caused by 
CRT leading to improved coaptation of the mitral valve leaflets through smaller LV volumes and 
better alignment of papillary muscles and chordae tendineae2.
Although these mechanisms all point to a beneficial effect of CRT on MR severity, less is known 
about whether MR reduction is a crucial element in determining CRT benefit. On the one hand, 
several studies found that persistence or worsening of MR after CRT may negatively impact 
cardiac function8,9 and (event-free) survival4,9,10, with more severe MR having a larger negative 
impact11,12. On the other hand, the exact nature of the link between MR improvement and 
CRT response is less clear, since a beneficial response to CRT also occurs in the absence 
of a reduction of MR4,13,14. In these cases, CRT benefit may be derived from, for example, 
an increase in cardiac function due to ventricular resynchronization or better atrioventricular 
coupling. Chronically, LV volume and hospitalizations may be reduced, while survival improves15. 
Therefore, we hypothesized that CRT may be of benefit even in the presence of structural MR, 
which by itself is not thought to be amenable to CRT because valve incompetence arises as a 
result of structural abnormality of the mitral valve apparatus.
A second question was which pacing mode would be most beneficial in case of structural MR. 
Three modes would deserve investigation: 1) optimum biventricular (BiV) pacing, 2) LV pacing 
with AV delay programmed at an intermediate value, thus allowing optimal fusion with intrinsic 
activation and 3) LV pacing at a short AV delay, thus creating LV pre-excitation.
98 | Chapter 5
It was the aim of the present study to investigate the acute haemodynamic effects of these 
pacing modes in a novel animal model of chronic MR+LBBB, and to compare the outcomes 
with those obtained in animals with isolated chronic LBBB. In the MR+LBBB model, MR was 
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MR Mitral regurgitation
LBBB Left bundle branch block
LV Left ventricle/ventricular
LVshort LV pacing with short AV delay







Animal handling was performed according to the Dutch Law on Animal Experimentation 
and the European Directive for the Protection of Vertebrate Animals used for Experimental 
and Other Scientific Purposes (86/609/EU). The protocol was approved by the Experimental 
Animal Committee of Maastricht University.
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Animal models
Experiments were performed, as described previously35, on adult mongrel dogs of either sex 
and unknown age, weighing 21.4 ± 1.7 kg. All experiments were performed under general 
anaesthesia. Thiopental (300 mg) was administered intravenously to induce anaesthesia, 
followed by continuous infusion of midazolam (0.25 mg/kg/h) and sufentanil (3 μg/kg/h) for 
maintenance.
In 8 dogs, MR was induced with closed chest using a customized electrophysiology catheter 
with a hook at the distal tip. The catheter was inserted into the carotid artery and introduced 
into the left ventricle, where the hook was used to grasp one or more chorda(e). The catheter 
was then retracted into a sheath and the chorda(e) was/were destroyed by cauterization. This 
process was repeated until intraprocedural echocardiographic and fluoroscopic evaluation 
indicated moderate-severe mitral regurgitation. Four weeks after MR induction LBBB was 
created by radiofrequency ablation of the left bundle branch during a closed-chest procedure16. 
LBBB was also created in 11 other animals that served as a control group.
Echocardiography
At baseline and at the end of the protocol, echocardiography was performed using a Vivid 
7 system (GE Vingmed, Horten, Norway). Left ventricular internal diameter during diastole 
(LVIDd) and systole (LVIDs) were determined in the parasternal short-axis section. Using the 
Teichholz formula, diameters were converted to LVEDV and LV end-systolic volume (LVESV), 
respectively. Subsequently, LV ejection fraction (LVEF) was calculated. For 1 dog, no sacrifice 
echocardiogram was available, and therefore this animal was excluded from echocardiographic 
analysis.
Haemodynamic measurements
During each surgical procedure and at the final day of the experimental protocol (week 20 in 
the MR+LBBB group and week 16 in the LBBB group), haemodynamic measurements were 
performed, using 7-Fr catheter tip manometers (CD-Leycom, Zoetermeer, the Netherlands) 
that were placed in the LV and right ventricle (RV). 2 dogs from the LBBB group were excluded 
from this analysis of haemodynamics over time due to missing baseline values.
For the sacrifice experiment, an additional catheter was inserted into the aorta for aortic 
pressure measurements, which were available for 6 of the MR+LBBB animals and 8 of the 
LBBB animals. Interventricular mechanical delay (IVMD) was calculated as the time shift that 
was necessary to maximize the cross-correlation coefficient between the upslopes of the LV 
and the RV pressure curves16. A positive value indicates that the LV upslope occurs first16.
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In a subset of animals the following measurements of cardiac output were compared to 
determine regurgitant fraction: 1) thermodilution using a Swann-Ganz catheter, introduced 
through the jugular vein and advanced into the pulmonary artery for determination of forward 
stroke volume (SV) and 2) SV calculated from echocardiography. The regurgitant volume 
through the mitral valve was then calculated as fraction of total SV:




assuming that SV trough the pulmonary valve is in equilibrium with the SV trough the aortic 
valve.
Pacing protocol
Pacing was performed using a transvenously introduced right atrial lead and an RV apical 
electrode on a transvenously introduced octopolar electrode catheter (Daig Livewire TC, 
Minnetonka, MN). After opening the thorax, a multielectrode array was wrapped around the 
ventricles to allow pacing the LV from various sites. In this study only data for pacing a mid-
lateral LV electrode are reported.
Before starting the pacing protocol, animals were haemodynamically stabilized using infusion 
with saline and dobutamine if necessary. This was particularly required in the MR+LBBB 
animals.
Atrial pacing (AAI mode) at ± 10 bpm above the intrinsic heart rate was used as baseline. After 
determining the intrinsic AV delay from the surface electrocardiogram (ECG), simultaneous 
BiV and LV only pacing was performed. BiV pacing was performed at AV delays 30 and 10 
ms shorter than intrinsic PR interval, to ensure full capture. For analysis we used the setting 
providing the largest increase in maximum rate of LV pressure rise (LVdP/dtmax) of the two 
(BiVbest). LV only pacing was performed at a wide range of AV delays, ranging from intrinsic AV 
delay -50 ms (LVshort) up to a maximum of +90 ms (aiming at fusion pacing)17. The AV delay 
that yielded an IVMD that was closest to the value halfway between that during LBBB and LV 
pacing at shortest AV delay was selected as LVfusion, because this has been previously shown 
to provide the best resynchronization17. Data were analysed using custom-written MATLAB 
software (MathWorks, Natick, MA).
Statistical analysis
All analyses were carried out using GraphPad Prism 8 (GraphPad Software, San Diego, 
USA). Values of the haemodynamic variables and % change from baseline (except for LV 
end-diastolic pressure (LVPed) and IVMD, where absolute change was used) were compared 
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between the different groups and settings using two-way mixed effects analysis of variance 
(ANOVA) followed by Bonferroni’s multiple comparisons test. We also used these statistical 
tests to compare the haemodynamic and echocardiographic data collected at baseline with 
those collected at sacrifice. For comparison of the 4-week data with baseline and sacrifice 
data, a separate repeated measures one-way ANOVA was performed, followed by Bonferroni’s 
multiple comparisons test. Where appropriate, we applied the Geisser-Greenhouse correction 
during ANOVA to account for possible violations of the assumption of sphericity. SV and 
regurgitant fraction in the two groups at sacrifice were compared using an unpaired t-test. P 
values ≤ 0.05 were considered statistically significant. Data are shown as mean ± standard 
deviation.
Results
Figure 1 shows images of a typical animal prior to induction of MR and 20 weeks later. MR 
(indicated by arrows) was demonstrated by colour Doppler echocardiography, retrograde flux 
of contrast medium injected into the LV and cardiac magnetic resonance imaging (MRI). After 
20 weeks of MR, significant enlargement of the LV cavity was visible, both on the long-axis MRI 










Fluoroscopy Cardiac MRIColour Doppler 
echocardiography
FIGURE 1. Imaging of MR with typical examples of colour Doppler echocardiography, fluoroscopy, cardiac MRI and 
2D echocardiography in canine hearts without (upper row) and with MR (lower low). Cardiac MRI and short-axis 
echocardiography were performed 4 months after inducing MR. Arrows point to the blood regurgitating through the 
mitral valve. MR = mitral regurgitation, MRI = magnetic resonance imaging. Adapted from 35.
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Haemodynamics and echocardiography over time
In the LBBB group, inducing LBBB led to a non-significant ~50% increase in LVEDV and a 
significant ~100% increase in LVESV (Table 1). A significantly larger dilatation was observed in 
MR+LBBB dogs, especially indicated by a ~120% increase in LVEDV (Table 1).
TABLE 1. Changes in echocardiographic parameters between baseline and medium-term MR+LBBB or LBBB
MR+LBBB (n = 7) LBBB (n = 11)
Baseline Sacrifice Baseline Sacrifice
LVEDV (ml) 52 ± 8 115 ± 55*# 46 ± 6 67 ± 18
LVESV (ml) 21 ± 2 44 ± 20* 20 ± 5 37 ± 13*
LVEF (%) 60 ± 3 60 ± 9# 57 ± 8 47 ± 10*
Regurgitant fraction (%) 58 ± 14# (n = 5) -1 ± 19 (n = 4)
Total SV (ml) 41 ± 13# (n = 5) 22 ± 2 (n = 4)
Forward SV (ml) 17 ± 5 (n = 5) 23 ± 5 (n = 4)
* = p ≤ 0.05 vs. baseline, # = p ≤ 0.05 vs. LBBB group at the same time point. Data are shown as mean ± standard 
deviation. For abbreviations, see list.
Chronic LBBB resulted in a significant 10% reduction in LVEF in the LBBB group (Table 1). 
In contrast, there was no significant change in echocardiographically determined LVEF over 
time in the MR+LBBB group (Table 1). However, measurements of mitral regurgitant fraction 
at sacrifice showed severe regurgitation (58 ± 14 %) in MR+LBBB animals, whereas there 
was no significant regurgitation in LBBB animals (-1 ± 19 %, Table 1). Echocardiographically 
determined total SV was significantly larger in the MR+LBBB animals than in the LBBB animals 
(Table 1). However, after subtraction of the regurgitant volume, forward SV tended to be less in 
the MR+LBBB than in the LBBB animals (Table 1).
Table 2 presents haemodynamic data recorded at various time points under closed-chest 
conditions. Over time, LVdP/dtmax decreased in both groups. In the MR animals 4 weeks of 
regurgitation hardly affected LVdP/dtmax, while chronic LBBB reduced it to a similar extent in 
the MR+LBBB and in the LBBB animals. LVPed increased somewhat after 4 weeks of MR in the 
MR+LBBB group, and partly recovered 16 weeks later.
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BL 4 weeks Sacrifice BL Sacrifice
Heart rate (bpm) 87 ± 13 99 ± 10 97 ± 18 97 ± 9 109 ± 17
LVdP/dtmax (mmHg/s) 1953 ± 239 1798 ± 305 1263 ± 359*# 1870 ± 242 1197 ± 210*
LVPed (mmHg) 6 ± 3 13 ± 6 10 ± 10 7 ± 3 5 ± 3
LVPsys (mmHg) 97 ± 9 97 ± 13 94 ± 15 107 ± 11 93 ± 12*
* = p ≤ 0.05 vs. baseline, # = p ≤ 0.05 vs. 1 month. Data are shown as mean ± standard deviation. For abbreviations, 
see list.
Effects of acute resynchronization therapy
During the open-chest pacing protocol, baseline values of LVdP/dtmax tended to be higher in 
the MR+LBBB than in the LBBB animals (1723 ± 500 vs. 1210 ± 277 mmHg/s, p = 0.10). In 
LBBB dogs, all pacing modes significantly increased LVdP/dtmax (Figure 2A and B, Table 3). 
In the MR+LBBB group, BiVbest tended to increase LVdP/dtmax (1909 ± 623 vs. 1723 ± 500 
mmHg/s at baseline, p = 0.14, Table 3). No significant differences or changes in LVdP/dtmax 
were observed between pacing modes or animal models (Figure 2A and B, Table 3). LV systolic 
pressure (LVPsys) did not change significantly during any of the pacing settings in either group 
(Table 3).
LVPed decreased slightly but significantly during BiVbest pacing in the MR+LBBB group and 
during LVshort pacing in the LBBB group (Table 3). Differences between baseline and LVshort and 
LVfusion pacing in the MR+LBBB group and between baseline and LVfusion pacing in the LBBB 
group were borderline significant (7 ± 5 vs. 4 ± 4 mmHg, p = 0.07; 7 ± 5 vs. 4 ± 4 mmHg, p = 
0.06 and 5 ± 4 vs. 4 ± 4 mmHg, p = 0.09, respectively (Table 3)).
When plotting the change in LVdP/dtmax against that of LVPed for all three pacing modes, LBBB 
animals consistently showed an increase in LVdP/dtmax, mostly in combination with a small 
decrease in LVPed. The MR+LBBB animals did not show an increase in LVdP/dtmax in a few 
cases but demonstrated a consistent decrease in LVPed (Figure 3).
Aortic systolic pressure (AOPsys) and aortic pulse pressure (AOPpulse) were not significantly 
affected by the various pacing modes in either group (Table 3). LVshort pacing reduced RV 
systolic pressure (RVPsys) relative to baseline and to BiVbest pacing in the LBBB group (Table 
3). None of the pacing settings significantly changed maximum rate of RV pressure rise 
(RVdP/dtmax) compared to baseline (Table 3).
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In both groups IVMD increased significantly from negative values during baseline to positive 
values during LVshort pacing (Figure 2C, Table 3). Additionally, in the LBBB dogs, LVshort pacing 
led to a more positive IVMD than BiVbest or LVfusion pacing (Figure 2C, Table 3).
Discussion
The main findings of this study are: 1) CRT increases LVdP/dtmax in LBBB and MR+LBBB 
animals, although the effect is somewhat less pronounced in the latter; 2) in MR+LBBB animals 
BiV and LV pacing decrease the moderately increased LVPed; 3) in both groups LV pacing with 
short AV delay (full capture) or with AV delay aiming at optimal fusion do not provide superior 
haemodynamic effect compared to BiV pacing. Summarizing, in this animal model of chronic 
structural MR combined with LBBB, CRT was able to improve cardiac pump function to an 
extent that is comparable with that in animals with lone chronic LBBB.
The MR+LBBB animal model
This model results in highly dilated hearts with LBBB. The more than doubling of LVEDV 
compared to healthy canine hearts (our baseline values) is quite similar to the difference in 
LVEDV between healthy individuals and heart failure patients7,18. Therefore, the MR+LBBB 
model may better mimic the hearts of CRT candidates than our conventional LBBB model 
(which shows dilatation to a lesser extent). The clinical similarity was also demonstrated by 
the fact that many of the MR+LBBB animals showed overt clinical symptoms, like abdominal 
fluid retention and poor exercise tolerance. Congestion in this model is also evidenced by the 
increase in LVPed, at least in the closed-chest situation. Undoubtedly, the creation of MR+LBBB 
is technically more challenging, because we observed a relatively large number of animals that 
died prematurely.
Other groups have used other ways to create heart failure, such as tachypacing at about 210 
bpm. However, the disadvantage of that approach is that the tachycardia is the dominant 
factor, reducing the haemodynamic benefit of CRT if this is applied at the same high heart 
rate19,20.
We observed a difference of a little more than 450 mmHg/s in LVdP/dtmax between sacrifice 
(Table 2) and baseline (start of the pacing protocol, Table 3) in the MR+LBBB dogs. This 
big difference may be due to the different situations in which the two values were recorded: 
the “sacrifice” value was recorded when the chest was still closed, while the baseline value 
was obtained after the chest had been opened and the dogs had been haemodynamically 
stabilized with intravenous saline and dobutamine as necessary.
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FIGURE 2. A. LVdP/dtmax change from baseline in % during the different pacing modes. B. LVdP/dtmax change from 
baseline in mmHg/s during the different pacing modes. C. IVMD during the different pacing modes. * = p ≤ 0.05 vs. 
BL in the respective group, # = p ≤ 0.05 vs. LVshort within the LBBB group. For abbreviations, see list.
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Haemodynamic improvements in the MR+LBBB animals
Acute increase in LVdP/dtmax due to CRT has been reported in animals21 as well as in 
patients22,23 with cardiac dyssynchrony. In our study, we observe similar increases in LVdP/dtmax 
in MR+LBBB and LBBB animals, despite the presence of structural MR in the former. The 
IVMD value at which we observe a relatively large increase in LVdP/dtmax in both animal models 
is fairly close to the one reported by Verbeek et al.21, which also suggests that the presence 
of MR does not fundamentally change the effect of resynchronization in our animal model. 
Moreover, while in some cases LV or BiV pacing did not lead to an increase in LVdP/dtmax in 
MR+LBBB dogs, the elevated LVPed was reduced in all cases.
It seems plausible that the reduction in LVPed is caused by the better contractility, thereby 
reducing backward failure. While in haemodynamic studies on CRT the change in LVdP/dtmax 
is the most dominant feature, clinically the reduction in LVPed may be at least as relevant. High 
LVPed is linked to congestion and thus symptoms of the patient24, meaning that its reduction 
may be beneficial. Moreover, reducing LVPed may lead to a reduction in LV dilatation and 
thereby to reverse remodelling in the longer term. Several studies have shown that reverse 
remodelling (reduction of LVEDV > 15%) is a valuable surrogate endpoint, predicting long-term 
clinical response25,26.
The results of CRT in our animal model of structural MR in combination with LBBB should be 
compared with care with those from patient studies involving functional MR, be it proportionate 
or disproportionate. As reported by Spartera et al., CRT may reduce MR in several ways: 
by increasing valvular closure force through increased LVdP/dtmax, normalizing mitral valve 
tethering, improving mitral valve dimensions and improving timing of atrial and ventricular 
contraction2. A few studies suggest that both LV only and BiV pacing may have beneficial 
effects on MR severity27–29. However, it is very unlikely that CRT with either setting has reduced 
MR in our structural MR+LBBB model. After all, MR due to the ruptured chordae tendineae is 
unlikely to be influenced by most of the factors mentioned above. In that sense, our MR+LBBB 
is the worst-case scenario for CRT, where a structural problem is present that it not amenable 
to CRT. Therefore, the most likely explanation for the better cardiac function (increase in 
LVdP/dtmax and reduction of LVPed) is ventricular resynchronization (alleviation of LBBB), thereby 
increasing ventricular contractility.
The present study only investigated the acute haemodynamic effects of CRT, but a few patient 
studies showed that CRT may still be beneficial if MR persists4,13, although possibly less than 
when MR is reduced by CRT4,10. However, patients in these cohorts did not have (severe) 
structural MR (like in our animal model). It would be interesting to see if our findings in the 
animal model are replicated in patients with structural MR, and, more importantly, whether any 
short-term improvement also relates to long-term benefit.
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Lastly, whether residual MR after CRT should be treated using mitral valve repair is under debate. 
The effects of implantation of a MitraClip device in CRT non-responders who also suffered from 
significant MR appear to be limited30. On the other hand, the COAPT trial indicated benefit of 
a MitraClip device over optimal medical therapy alone on the combined end point of heart 
failure hospitalizations and all-cause mortality in patients who had previously received CRT31. 
An important difference is that the former study did not include a control group but predicted 
survival scores using patient characteristics, while the latter directly compared MitraClip plus 
optimal medical therapy with optimal medical therapy alone. Moreover, the group sizes were 
very different (42 vs. 614 patients).
Benefit of BiV and LV only pacing
Our findings regarding BiV and LV only pacing corroborate outcomes of previous studies in 
patients and in dogs, showing that both pacing modes have similar haemodynamic benefit in 
LBBB27,32. A chronic study that focused on LV pacing without fusion demonstrated the same 
outcome33. On the other hand, in a study using the adaptive CRT algorithm, optimized LV 
fusion pacing showed a benefit compared to conventional BiV pacing with regard to clinical 
outcome34. Whether the comparable acute benefits of BiV and LV only pacing we observed 
would lead to comparable benefit in the long term, or whether LV only fusion pacing is a 
superior method to resynchronize hearts with structural MR also remains to be investigated.
Limitations
The number of animals that was studied was small. Since this was an animal model, MR and 
LBBB were induced in an artificial way. Measurements were done under general anaesthesia 
and all values were compared to one baseline measurement (rather than alternating between 
baseline measurements and pacing settings). Forward flow into the aorta was not measured, 
although it was estimated in a subgroup of animals. Finally, extrapolating results from acute 
animal studies to long-term clinical effect should be done with care.
Conclusions
In an animal model of structural MR combined with LBBB, CRT was able to improve cardiac 
pump function, although the effect was less pronounced than in isolated LBBB.
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Abstract
Aims Cardiac dyssynchrony in patients with repaired Tetralogy of Fallot (rToF) has been 
attributed to right bundle branch block (RBBB), fibrosis and/or the patches that are inserted 
during repair surgery. We aimed to investigate the basis of abnormal activation in rToF patients 
by mapping the electrical activation sequence during sinus rhythm (SR) and right ventricular 
(RV) pacing.
Methods A total of 17 patients were studied (13 with rToF, 2 with left bundle branch block 
(LBBB) and 2 without RBBB or LBBB (non-BBB)) during medically indicated cardiac surgery. 
During SR and RV pacing, measurements were performed using 112-electrode RV endocardial 
balloons (rToF only) and biventricular epicardial sock arrays (4 of the rToF and all non-rToF 
patients).
Results During SR, functional lines of block occurred in 5 rToF patients while RV pacing 
caused functional blocks in 4 rToF patients. The line of block persisted during both SR and RV 
pacing in only 2 out of 13 rToF patients. Compared to SR, RV pacing increased dispersion of 
septal activation, but not dispersion of endocardial and epicardial activation of the RV free wall. 
During pacing, RV and left ventricular activation dispersion of rToF patients were comparable 
to those of the non-rToF patients.
Conclusion The results of the present study indicate that the delayed activation in the RV of 
rToF patients is predominantly due to block(s) in the Purkinje system and that conduction in 
RV tissue is fairly normal.
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Introduction
Tetralogy of Fallot (ToF), the most common congenital cyanotic cardiac disease, is characterized 
by a ventricular septal defect (VSD), overriding aorta, pulmonary stenosis and concomitant 
hypertrophy of the right ventricle (RV)1. During surgery, which is usually performed at a very 
young age, the VSD is closed and the pulmonary stenosis is alleviated. While surgery has 
a high chance of success to restore anatomy, it often results in right bundle branch block 
(RBBB), post-operative pulmonary insufficiency and residual stenosis. These three conditions 
are potentially harmful for proper cardiac function and may negatively affect the prognosis of 
patients with repaired Tetralogy of Fallot (rToF).
Patients with rToF often display dyssynchrony, and larger dyssynchrony is correlated to lower 
exercise capacity and increased risk of ventricular arrhythmias2.
An obvious candidate cause of this dyssynchrony is damage to part of the rapid conduction 
system, in particular the right bundle branch3. Electrophysiological studies performed during 
rToF surgery showed RBBB3,4 and also left anterior hemiblock has been found post-surgery5.
However, structural abnormalities (like fibrosis) due to longer-lasting RV overload and related 
RV dilation, surgical scar and the patch used to relieve pulmonary stenosis may cause or 
aggravate the dyssynchrony6,7.
The present study aims to assess if, and to what extent, abnormal activation in rToF hearts 
is due to structural tissue abnormalities, by examining the presence of conduction block and 
dispersion of activation using detailed endo- and epicardial mapping. Measurements during 
sinus rhythm (SR) and RV pacing allowed us to distinguish between the conductive effects 
of the His-Purkinje system and myocardial tissue properties and also between structural and 
functional blocks. Data from rToF patients was compared with a small group of non-rToF 
patients.
Materials and Methods
Study population and mapping array
Studies were performed at Toronto General Hospital, between 1995 and 2008. This study 
was approved by the University Health Network Ethics Review Board. All patients provided 
informed consent prior to inclusion.
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During medically indicated cardiac surgery, detailed RV mapping was performed in 13 rToF 
patients (4 women, 9 men, age 37 ± 8 (mean ± standard deviation)), using an RV cavity-
shaped endocardial balloon array consisting of 112 bipolar electrodes (Figure 1A). Additionally, 
in 4 of these patients, an epicardial sock array with 112 bipolar electrodes (Figure 1B) was used 
to map both left ventricular (LV) and RV activation. The latter array was also used in 2 patients 
with left bundle branch block (LBBB)(1 woman, 1 man, age 61) and 2 patients without either 
RBBB or LBBB (non-BBB, both men, age 64).
15-25
 mm
FIGURE 1. A. The endocardial right ventricular (RV) balloon array. The thumb-like structure on the right side was 
positioned inside the RV outflow tract. B. The epicardial sock array.
The arrays have been described in previous publications, that already addressed some aspects 
of cardiac activation during SR in some of the patients described in this paper8,9. Briefly, the 
112 electrode pairs on each of the arrays were divided over 14 vertical splines of 8 pairs each. 
For all 112 channels, unipolar (sampling rate 1000 Hz, filtering 0.5 – 200 Hz) and bipolar signals 
(sampling rate 2000 Hz, filtering 28 – 750 Hz) were recorded simultaneously.  The electrodes 
were assigned a region (details in legends to Figures 2 and 3).
In the 4 patients where both arrays were used, the sites of earliest activation on both sock 
and balloon were overlaid during analysis of paced maps, to ensure proper assignment of the 
electrodes on the sock to either LV or RV on the epicardium.
A B
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In order to increase the number of observations in LBBB hearts, relevant data from literature 
describing 4 patients who underwent electrocardiographic (ECG) imaging during both SR and 
RV pacing were included10.
Data acquisition and analysis
Mapping was performed after the initiation of cardiopulmonary bypass. Unipolar and bipolar 
electrograms were recorded, using an epicardial needle stitched onto the base of the heart 
as a reference. Measurements were performed during SR and during RV pacing from an 
epicardial site.
Unipolar and bipolar electrograms were analysed using custom-written software to determine 
local activation times, using the onset of the QRS complex or the middle of the pacing spike 
as time reference.
Using custom-written MATLAB software (MathWorks, Natick, MA), activation patterns were 
visualized in activation maps, and several parameters were calculated:
• Average activation time (ms) per region: allowing gross comparison of the order of 
activation between regions
• Regional activation dispersion (ms): the difference between the 5 and 95% percentile 
of activation times in each region
• Total activation time (ms): the latest activation time of the epicardial sock array
Statistical analysis
Statistical analysis was performed using GraphPad Prism 8 (GraphPad Software, San Diego, 
USA). Differences in activation times and regional activation dispersions per region of the 
balloon were assessed using a Friedman test, followed by a Dunn’s multiple comparison test. 
Activation dispersions of the whole balloon during SR and pacing were compared using a 
Wilcoxon matched pairs signed rank test. A p-value ≤ 0.05 was considered to be significant. 
Due to the small number of patients who were examined using the sock array, no statistical 
analysis was performed for this data.
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Results
Endo- and epicardial activation maps
For the majority of the rToF patients, endocardial RV activation (measured on the balloon array) 
started on the septum and then spread to the RV free wall (RVFW) and RV outflow tract (RVOT)
(Figure 2A and C). Upon RV pacing, the RVFW became activated earlier than the septum and 
the RVOT (Figure 2B and D). 
FIGURE 2. Activation maps of the right ventricular (RV) balloon for two patients with repaired Tetralogy of Fallot 
(rToF), during sinus rhythm (A, C) and pacing (B, D). The white lines indicate the borders between the different areas: 
RV free wall (RVFW), septum (SEPT) and RV outflow tract (RVOT). The red arrows point to the structural line of block. 
Grey dots denote electrodes with poor signal quality, omitted from analysis.
Both during SR and during pacing functional blocks occurred. The locations of these blocks 
varied considerably between patients and between activation modes. In 7 rToF patients, 
activation progressed fairly regularly during SR, while 5 patients had a functional block that 
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disappeared during pacing (example of the latter in Figures 2A & B). These functional blocks 
occurred in the RVOT (n = 3), septum (n = 2), RVFW (n = 1) or in the septum/RVOT border area 
(n = 1). (Note that a patient can have more than one block.)
In the remaining patient and in one of the patients with functional block, a structural block was 
present (example in Figures 2C & D). During pacing, functional blocks appeared in 4 patients, 
in the RVOT (n = 3), septum (n = 1) and in the septum/RVFW border area (n = 1). During SR, 
no blocks were present in 2 out of these 4 patients.
During SR, the RVFW was the main late activated area in two of the four rToF patients mapped 
epicardially, (example in Figure 3A, paced map in Figure 3B), whereas in one patient this was 
the antero-basal area of both RV and LV (Figure 3C) and in another patient the LV.
FIGURE 3. Activation maps of the epicardial sock for two patients with repaired Tetralogy of Fallot (rToF), during sinus 
rhythm (A, C) and pacing (B, D). One spline is aligned with the left anterior descending artery (LAD), the white lines 
indicate the borders between the different areas: left ventricle (LV), right ventricle (RV) and LAD. Grey dots denote 
electrodes with poor signal quality, omitted from analysis.
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For the non-BBB patients, during SR the latest activated area was found in the LV (1 patient, 
Figure 4A) or the RV (1 patient), while in both LBBB patients, the latest activation occurred in 
the LV (Figure 4C). In all patient groups, RV pacing created early activation near the pacing 
electrode and spread of activation towards the opposite wall.
FIGURE 4. Activation maps of the epicardial sock for one patient without either right or left bundle branch block (non-
BBB)(A and B) and one patient with left bundle branch block (LBBB)(C and D) during sinus rhythm (A, C) and pacing 
(B, D). The red arrows point to the structural line of block. Grey dots denote electrodes with poor signal quality, 
omitted from analysis. Area abbreviations as in Figure 3.
No epicardial lines of block were observed during SR in any of the four rToF patients, whereas 
during RV pacing, a line of block occurred in the LV in one patient (Figure 3D). In the non-BBB 
patients, no lines of block were observed during either SR or RV pacing. In one of the LBBB 
patients, a persistent line of block occurred in the LV (Figure 4C and D), while in the other LBBB 
patient, a line of block was observed during LV pacing.
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In summary, functional blocks, that (dis)appeared during ventricular pacing, were found in 8 
out of 13 rToF patients, while only 2 had a structural conduction block. One of the two LBBB 
patients had a functional block and the other patient had a structural block.
Quantification of cardiac activation patterns
Data from all rToF patients show that during SR the RVFW (92 ± 10 ms, mean ± standard 
deviation, p = 0.001) and RVOT (85 ± 19 ms, p = 0.068) are later activated than the septum 
(57 ± 11 ms), whereas RV pacing results in earlier activation of the RVFW (57 ± 9 ms; p = 0.001 
vs. SR) and later activation of the septum (94 ± 18 ms; p < 0.001 vs. RVFW) and RVOT (114 
± 22 ms; p < 0.0001, Figure 5A).
Average epicardial LV activation time of rToF patients (67 (55 - 83) ms, mean and range) and 
non-BBB patients (51 and 77 ms) was comparable, whereas it was larger in the LBBB patients 
(114 (88 - 144) ms) than in all rToF and non-BBB patients (Figure 5B). Pacing increased the 
average epicardial LV activation time for all but one patient (rToF 101 (73 - 132) ms; non-BBB 
98 and 183 ms; LBBB 133 (121 - 149) ms). Mean increase in rToF was 34 ms, 77 ms in non-
BBB and 19 ms in LBBB (Figure 5B). On average, mean RV activation time was larger in rToF 
patients (95 (73 - 117) ms) than in the non-BBB (21 and 113 ms) and the LBBB patients (46 
(29 - 84) ms; Figure 5C). During pacing, average RV activation occurred consistently earlier in 
the rToF patients while it became later in the other patients (rToF 65 (53 - 71) ms, non-BBB 61 
and 150 ms, LBBB 85 (36 - 188) ms). The mean change in activation times was -30 ms (rToF), 
+39 ms (non-BBB) and +38 ms (LBBB); Figure 5C).
Total epicardial activation times were comparable between rToF patients (161 ms (151-170) 
mean and range), LBBB patients (174 ms for both) and one of the non-BBB patients (95 and 
150 ms) during SR. During ventricular pacing, total activation time increased in the non-BBB 
patients (to 146 and 242 ms) and LBBB patients (to 220 and 224 ms), whereas it did not 
consistently change in the rToF patients (161 ms (133-188)).
Activation dispersion
The rToF patients had a total activation dispersion within the RV balloon of 93 ms (range 49-
114 ms) during SR. Activation dispersion did not differ between septum (57 ± 27 ms, mean 
± standard deviation) and RVFW during SR (61 ± 15 ms), but during pacing, septal activation 
dispersion increased significantly (to 78 ± 16 ms; p = 0.038 vs. septum during SR and p = 
0.027 vs. RVFW during pacing; Figure 5D). This increase is likely to be largely responsible for 
the significant increase in total activation dispersion during RV pacing (to 114 ms, (83-141 ms), 
p = 0.006).
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During SR, epicardial LV activation dispersion was smallest in the non-BBB patients (35 and 
62 ms), intermediate in 3 out of 4 rToF patients (82 (64 - 128) ms, mean and range) and largest 
in the LBBB patients (110 and 132 ms; Figure 5E). During RV pacing, LV activation dispersion 
increased in all but one rToF and one LBBB patient so that activation dispersion became 
comparable between the three patient groups (rToF 103 (65 - 125) ms, non-BBB 92 and 131 
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FIGURE 5. Average activation times in different zones of the endocardial RV balloon array (A) and at the LV (B) and 
RV epicardium (C). Dispersion of activation times in different zones of the endocardial RV balloon array (D) and at 
the LV (E) and RV epicardium (F). Black symbols denote sinus rhythm (SR), red symbols denote pacing (PACE), other 
abbreviations as in Figures 2, 3 and 4. Blue triangles in panels B and C denote data obtained from a study using 
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On average, epicardial RV activation dispersion was larger in the rToF patients (74 (63 - 101) 
ms) than in the other patients (non-BBB 26 and 62 ms, LBBB 31 and 65 ms; Figure 5F). 
This dispersion decreased upon RV pacing in 2 of the 4 rToF patients, while increasing in the 
non-BBB patients and one LBBB patient. Importantly, this made RV dispersion of activation 
comparable between the patient groups (rToF 59 (54 - 66) ms; non-BBB 70 and 132 ms, LBBB 
57 and 58 ms) and one non-BBB patient showed the largest activation dispersion (Figure 5F).
Discussion
The main findings of the present study are that in rToF patients 1) structural lines of block 
in the RV are rare; 2) dispersion of activation in both endo- and epicardium of the RVFW is 
virtually unchanged between SR and RV pacing and 3) during RV pacing, epicardial activation 
dispersion in both RV and LV is comparable with that in non-rToF patients. These findings 
indicate that conduction properties of the working myocardium are fairly well-preserved and 
that the delayed activation in the RV of rToF patients is likely in large part due to blocks in the 
Purkinje system. The latter has important implications for the potential application of cardiac 
resynchronization therapy (CRT) in these patients. The persistence of lines of block in only 2 
out of the 13 patients indicates that structural regions of block were present in only a minority 
of rToF patients. Functional blocks during SR were present in about 40% of the patients, and 
during pacing in approximately 30%.
Lines of block in rToF patients
In the majority of rToF patients (11/13), there were no lines of structural block that persisted 
during both SR and pacing. We consider this finding to be evidence for the idea that a defect of 
(part of) the rapid conduction system, in particular the right bundle branch, is the primary cause 
of the abnormal conduction in rToF hearts. Indeed, RBBB morphology of the QRS complex is 
a common finding after surgical repair of ToF6,11, which has been attributed to damage to the 
right bundle branch due to VSD closure, RV ventriculotomy or resection of stenotic tissue3,4.
The evidence of lines of functional block may, however, point to some conduction problems at 
the tissue level, such as fibrosis and electrical remodelling. In 8 of the 13 rToF patients, functional 
lines of block were visible endocardially during SR and/or pacing. The (dis)appearance of lines 
of block may be explained by the fact that collagen can affect conduction in an anisotropic 
manner, meaning that activation of the tissue in one direction will lead to conduction block, 
while conduction in another direction is not negatively influenced7,12. Since the functional 
blocks often occurred in the RVOT (in 5/8 patients who had functional block during either SR 
or pacing), we may speculate that surgical scars are (partially) responsible for these blocks.
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Additionally, since fibrotic tissue has been found outside of the patches in RVOT and VSD 
both in rToF patients13 and in animal models of rToF14,15, fibrosis may also have played a role 
in functional blocks outside of the RVOT. However, delays in regions with fibrosis are also 
governed by the length of fibrotic strands, with short strands hardly affecting conduction7. It is 
therefore possible that fibrotic tissue did not automatically cause conduction block, which may 
be an explanation for the relative rareness of epicardial functional conduction blocks in rToF 
patients (1 out of 4).
Another potential cause of lines of functional block is electrical remodelling and one protein that 
may be involved in this process is connexin 43 (Cx43). Its expression can decrease, and it may 
be found in a more lateral location on cardiomyocytes. Cx43 abnormalities have been shown 
in an animal model of rToF14,15, and also in RV samples of rToF patients16.
Unfortunately, no imaging data regarding cardiac fibrosis was available in any of the patients, 
but we can speculate about the reasons for finding structural blocks in the RVOT, particularly at 
the junction of the RVFW and the septum. Firstly, fibrotic tissue has been frequently observed 
at the RVFW-septum junction in patients with rToF17. Secondly, even in normal hearts tissue 
architecture is less organized at the ventricular junctions than elsewhere in the ventricular 
walls18. It should be noted, however, that the patients that were included in the present study 
all underwent electrical mapping to search for foci of arrhythmia, meaning that they represent 
the patients with the most severely affected tissue properties in their respective categories.
Activation dispersion in rToF during ventricular pacing
In this study we used ventricular pacing to specifically test conduction properties in the working 
myocardium. Doing so, it was observed that epicardial activation dispersion in both RV and 
LV of rToF patients was quite comparable to that in non-rToF patients. Therefore, these data 
indicate that even if there are demonstrable tissue conduction abnormalities (structural and/or 
functional block), overall conduction is hardly affected.
During RV pacing, endocardial RV activation dispersion did not increase in the RVOT or RVFW. 
This further supports the notion that cardiac tissue properties of the majority of the RV areas 
are probably similar, since e.g. extensive fibrosis, electrical uncoupling or patch are expected 
to create zones of conduction delay or blocks6,7,12. The fact that the endocardially measured 
RVFW activation dispersion and its epicardial equivalent are in the same range and show 
comparable behaviour further underlines the relative tissue homogeneity in rToF hearts.
Extrapolation to resynchronization of rToF patients
Since RBBB in rToF patients is so prevalent, RV resynchronization through CRT is a tantalizing 
possibility. This may be especially true in hearts with RV hypertrophy (which may remain 
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present in patients with rToF, due to residual pulmonary stenosis), since studies in dogs have 
shown that the negative hemodynamic effects of RBBB are more pronounced if the RV is 
hypertrophied19. Moreover, dyssynchrony itself leads to extensive ventricular remodelling, 
potentially further worsening ventricular function and increasing the risk of arrhythmia20.
Analogous to the abnormal contraction pattern observed in the LV of patients with LBBB, 
patients with rToF and RBBB show dyssynchronous contraction in the RV21. Indeed, several 
small studies have shown that CRT can improve synchrony of activation and cardiac function 
in patients with rToF, either through RV pacing aimed at fusion with the intrinsic activation 
wavefront or through biventricular pacing22–24. Even more interesting is the finding in a 
combined patient and computer simulation study that correction of the dyssynchrony in rToF 
patients may be of larger benefit to RV function and exercise tolerance than surgical correction 
of pulmonary valve regurgitation25.
Although we did not investigate CRT, our findings underline the potential to resynchronize 
the ventricles because our data primarily indicate conduction blocks proximal in the rapid 
conduction system. Moreover, because functional lines of block are also commonly found in 
patients with LBBB26 (in whom CRT has become an established treatment27) we do not believe 
that their presence precludes successful CRT in rToF patients. In addition, activation dispersion 
in the RV and LV during ventricular pacing was comparable in rToF and in LBBB patients.
Limitations
This study has several limitations. Firstly, the number of patients that was studied was small 
and no healthy controls were included. Both are not surprising given the invasive nature of 
the mapping procedure. Only one pacing site was studied, and this site was not standardized 
for all patients. In comparison to studies focusing on the presence of isthmuses leading to 
ventricular arrhythmias28, the density of electrodes in the most basal part of the RVOT of the 
mapping arrays used in the present study may have been somewhat lower.
Conclusions
In rToF patients, structural lines of block are rare. Dispersion of activation in both endo- and 
epicardium of the RVFW is virtually unchanged between SR and RV pacing. Furthermore, 
activation dispersion in both RV and LV during pacing is comparable with that in non-BBB and 
LBBB patients. These findings indicate that the delayed activation in the RV of rToF patients 
is predominantly due to blocks in the Purkinje system, while conduction properties in the RV 
are relatively normal.
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In the context of left bundle branch block (LBBB) resynchronization of depolarization through 
cardiac resynchronization therapy (CRT) and its effect on pump function and long-term 
outcome have been studied extensively. This thesis aimed to shed some light on aspects of 
CRT that have not yet been studied in detail.
In chapters 3 and 4 we investigated remodelling of repolarization following CRT, using changes 
in T wave area as a marker, both during CRT and after short interruption of CRT. We showed 
that repolarization remodelling occurs rapidly (within 2 weeks of starting CRT). Simulations in a 
patient-specific computational model demonstrated that this repolarization remodelling leads 
to lower dispersion of repolarization. Additionally, more repolarization remodelling was linked to 
a better echocardiographic response to CRT.
In chapter 5 we explored the effects of CRT in an animal model of LBBB and structural 
mitral regurgitation (MR). While CRT most likely does not influence this kind of MR, we found 
evidence that CRT still increases left ventricular (LV) pump function.
Finally, in chapter 6, we investigated the tissue conduction properties of patients with repaired 
Tetralogy of Fallot (rToF) and compared these patients to a small group of LBBB and non-
bundle branch block (non-BBB) patients. We found that structural conduction blocks were rare 
in patients with rToF and that tissue conduction properties of the right ventricular (RV) free wall 
were comparable between rToF and other patients.
Repolarization remodelling following CRT
Our finding that the change in depolarization pattern by CRT influences repolarization is in line 
with previous studies showing that T area and/or amplitude increase when the CRT device 
is switched off after a period of pacing1–3. These previous studies demonstrated that these 
changes already occurred well within a week after initiation of CRT1–3.
New aspects in our studies, however, are the longer time period that was investigated (14-90 
days vs. 6 months in our studies), the more frequent vectorcardiographic (VCG) recordings and 
the larger number of patients involved (11-23 biventricularly paced patients vs. 25 (chapter 3) 
and 76 (chapter 4)). Moreover, to the best of our knowledge, we are the first to investigate a 
possible link between T area changes and increase in left ventricular ejection fraction (LVEF). 
Furthermore, we elaborated on the use of T wave area during brief interruption of CRT (CRT-
OFF) as marker of dispersion of repolarization. To this purpose we also made use of a computer 
model that linked the increase in T area during CRT-OFF to a change in repolarization sequence, 
indicating a reduction in dispersion of repolarization during longer-lasting CRT.
132 | Chapter 7
Upon starting CRT, T area is acutely reduced. This reduction seems to be explained by the 
fact that during CRT the two depolarizing wavefronts from the ventricular pacing electrodes 
give rise to two repolarization wavefronts that merge and cancel each other, thus reducing T 
area. Our findings extend the findings by Wecke et al., who also found a reduction in T area 
during CRT1.
Adaptation in repolarization due to longer-lasting altered activation sequence has been 
evidenced by T wave changes following onset of RV pacing or LBBB4–6. Under those conditions 
the transition from synchronous to dyssynchronous activation led to an immediate large 
increase in T wave amplitude and area, followed by a moderate reduction in these parameters 
during longer-lasting dyssynchrony4–6. Adaptations in repolarization have also been indicated 
by an abnormal T wave occurring after brief interruption of RV pacing: return of the narrow 
QRS complex was accompanied by a T wave pointing in the direction of the QRS complex 
during pacing (“T wave memory”)5,7. Studies in rabbit hearts demonstrated that such changes 
in repolarization may occur due to prolongation of the action potential duration (APD) in early-
activated regions and APD shortening in later-activated regions8.
Our research differs from these aforementioned studies, since during CRT the activation 
changes from dyssynchronous to more synchronous, so opposite to the work investigating 
the effect of chronic RV pacing or LBBB. Like the aforementioned publications, we did observe 
an abnormal T wave upon interrupting CRT in our analysis. However, we did not see a chronic 
reduction in T area over time during continuous CRT (CRT-ON). This observation may be 
explained by dominance of the CRT-induced bifocal spread of activation over the repolarization 
sequence, which may conceal regional repolarization changes.
Nonetheless, a small study (11 patients) by Padeletti et al. did find a decrease in T wave 
amplitude during persistent CRT3. In that study, however, T amplitude increased immediately 
upon start of CRT, compared to the baseline situation. Moreover, in that study, the T amplitude 
also remained higher than baseline after 60 days of CRT. Possible explanations for these 
different findings are differences in composition of the patient cohorts and differences in 
measurement of the VCG. In our study, for example, the majority of patients was in NYHA 
class I-III whereas in the study by Padeletti et al., all patients were in NYHA class III-IV. While 
we constructed the VCG from the 12-lead electrocardiogram (ECG)(validated by Engels9 et 
al.), Padeletti et al. used direct measurement from the Marquette system. Finally, the first 
measurement during CRT was on the day after implantation in our studies but immediately 
upon device implantation by Padeletti et al.
Interestingly, brief interruption of CRT unveiled changes in T area over time that were not 
(or hardly) observed during CRT-ON. During CRT-OFF T area was also the parameter that 
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showed changes more pronouncedly than several commonly used markers of repolarization, 
such as QT interval, T peak-to-end interval (Tp-e) and precordial QT dispersion. One of the 
possible implications of the present study may be that briefly switching off the CRT device and 
measuring T area may be used to investigate repolarization remodelling in greater detail.
An advantage of the use of T area to study this phenomenon is that it is easy to objectively 
and reliably quantify. After all, T area is largely determined by the amplitude of the major part of 
the T wave. In contrast, determining the end of the T wave for repolarization markers like QT 
interval and Tp-e can be subjective10, although recent development of an algorithm may make 
these measurements more objective11.
Relation between repolarization remodelling and arrhythmias?
There is conflicting data on the effect of CRT on the occurrence of arrhythmias. A short-
term study in patients indicated a potential pro-arrhythmic effect of CRT evidenced by 
increased dispersion of repolarization12. When epicardial pacing was applied to animal tissues 
an increase in dispersion of repolarization was also observed, and arrhythmias could be 
induced after administering potassium channel blockers13. However, a reduction in arrhythmia 
incidence following CRT in responders was found in several other studies, including clinical 
trials, that also demonstrated an increased arrhythmia incidence in non-responders14,15. Such 
findings suggest that the reduction in arrhythmias is related to the reverse remodelling in CRT 
responders.
In general, a larger dispersion of repolarization is considered to be a risk factor for the 
occurrence of arrhythmias. Despite all the changes we observed in repolarization parameters, 
arrhythmia incidence was low and did not change over time in the patient cohorts we studied. 
The fact that there were very few ventricular arrhythmias is a likely reason for this finding. 
This observation becomes even more interesting when considering that biventricular pacing 
is not present during all heartbeats, because even during well-installed CRT the percentage 
biventricular pacing is usually less than 100%, leaving ~1-5% of the beats with the same 
increased dispersion of repolarization as we observed during CRT-OFF16.
On the one hand, finding a possible relation between repolarization and arrhythmias would 
require a considerably larger study. On the other hand, there are at least two other potential 
explanations for a lack of a clear relation between dispersion of repolarization and arrhythmias. 
First, T area and the other repolarization parameters are fairly global measures of repolarization 
dispersion, while local repolarization dispersion is more likely to be particularly important for 
arrhythmia risk17. Second, as shown by the patient-specific computational model, in CRT 
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patients the repolarization “waves” are likely large and broad with small local repolarization 
gradients. This has also been shown by direct mapping in a similar patient cohort18. Under 
such conditions it is unlikely that re-entry occurs.
Possible mechanisms of repolarization remodelling
Mechano-electrical coupling has been proposed as an explanation for the repolarization 
remodelling observed during both LBBB and CRT. Sosunov et al. provided elegant evidence 
for this idea by showing that in rabbit hearts reducing or preventing pressure development in 
the ventricles precluded the development of T wave memory19. A more cellular mechanistic 
view was provided by Kuijpers et al.20 As the heart adapts to the new activation sequence, 
calcium currents may change locally to re-homogenize the amount of work each region has 
to perform20. According to this assumption, in early-activated areas calcium currents may 
increase to compensate for the reduction in work, which in turn increases local APD. The 
opposite may be true for areas that are activated late20. Over time this may lead to a lower 
dispersion of repolarization times20, which can cause a reduction in T area.
Data in chapter 3 indicate that repolarization remodelling precedes changes in LVEF. This may 
seem to contradict a relation between repolarization and contractile remodelling as described 
above. However, both LVEF and strain are related to LV volumes and volume reduction after 
CRT takes several weeks21,22.
Remodelling in impulse conduction?
While the focus of our work was on changes in the T wave, we noticed some unexpected 
changes in the QRS complex during longer-lasting CRT. In chapter 3, we observed a modest, 
transient increase in QRS area during the first month of CRT. This increase seems to disappear 
after a few months, which may explain why we did not observe this phenomenon in chapter 4, 
where we only studied baseline and remodelling after 6 months.
However, in chapter 4, we found that QRS area did not change between baseline and 
6-month follow-up in patients with a large increase in T area during CRT-OFF, whereas QRS 
area decreased in the patients with a small change in T area.
In an attempt to link these two observations, we stratified 21 patients from chapter 3 by the 
median T area change we observed in chapter 4 (smaller than 41 mV·ms: LOW, larger than 
41mV·ms: HIGH). Although differences were not statistically significant (likely due to the small 
group sizes: LOW = 5 patients, HIGH = 16 patients), QRS area tended to be smaller in the 
LOW subgroup than in the HIGH subgroup at baseline and during all CRT-OFF measurements 
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(Figure 1). In both subgroups QRS area showed a similar trend of a temporary increase during 
the first month of CRT. However, the reduction in QRS area we observed after 6 months in the 
LOW subgroup in chapter 4 is not visible in the LOW subgroup shown in Figure 1.




































































































































































































































FIGURE 1. QRS area over time in 21 patients from chapter 3, for whom baseline and 3- or 6-month ECGs with stable 
morphologies were available. Patients were stratified according to T area change between baseline and late follow-
up during CRT-OFF (LOW = smaller than 41 mV·ms, 5 patients; HIGH = larger than 41 mV·ms, 16 patients). Red and 
black lines represent ON and OFF measurements for the indicated subgroup. Blue symbols represent values from 
baseline and at 6 months CRT-OFF from chapter 4, Figure 2B. BL = baseline, 1-5D = 1-5 days, 2W-1M = 2 weeks-1 
month, 3M-6M = 3-6 months, CRT = cardiac resynchronization therapy, ECG = electrocardiogram, ON = during CRT, 
OFF = during brief interruption of CRT.
A large QRS area suggests unopposed depolarization23. Animal studies indicated that 
dyssynchrony can bring about abnormal connexin 43 (Cx43) expression and localization24,25. 
Stretching cultured cardiomyocytes causes Cx43 relocalization26, and major local mechanical 
changes can be induced by dyssynchrony. Taken together, th se findings support the idea 
that myocardial impulse conduction may be affected by dyssynchrony-induced mechanical 
derangements. Moreover, cellular uncoupling can lower QRS amplitudes27. Therefore, it may 
be speculated that a more polarized Cx43 localization and/or an increase in Cx43 expression 
may be responsible for the increase in QRS area after CRT, through a more uniform (but not 
overall faster) depolarization.
Future perspectives
Given the relatively small number of studies on repolarization in CRT patients, the present 
studies may give cause for further research on this topic. While we have shown a positive 
correlation between T wave area change and echocardiographic response during medium-
term follow-up, it is unclear whether a larger T area change is also linked to a larger clinical 
benefit. Studies with more patients and longer follow-up are needed to additionally investigate 
the connection between repolarization remodelling and clinical CRT response, including 
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arrhythmia risk. Better investigation of the relation between T area changes and arrhythmias 
will require a larger study than the one performed by us, in particular in order to examine 
subgroups of patients that are known to be more vulnerable to arrhythmias, such as patients 
with a history of ischemic cardiomyopathy.
Additionally, to the best of our knowledge, it is not known whether more synchronous 
repolarization following CRT may also lead to improved ventricular relaxation, which in turn 
could beneficially affect diastolic function. In this regard it is interesting to note that the first 
studies on acute haemodynamic response to CRT found a consistent improvement in systolic 
function (maximum rate of LV pressure rise, LVdP/dtmax), but changes in diastolic function, as 
quantified by maximum rate of LV pressure fall (LVdP/dtmin) and the time constant of LV pressure 
decay (tau) were non-significant or small and inconsistent28,29. In canine hearts with 8 weeks 
of LBBB it was found that LVdP/dtmin decreased from approximately -1600 to -1870 mmHg/s 
immediately after start of CRT and further decreased significantly to about -2020 mmHg/s30. 
In this study electrical contact mapping also showed an altered relation between activation 
time and APD, agreeing with the changes observed in the computer simulations in chapter 3. 
Therefore, it seems worthwhile to further investigate the relation between repolarization and 
relaxation changes in CRT patients.
Furthermore, a more detailed mechanistical study that can provide additional information 
about the role of mechano-electrical coupling would be of interest. Such a mechanistical 
study could, for example, make use of a new module of the CircAdapt computer model that 
provides, through the buffering of calcium by troponin, bidirectional coupling between the 
O'Hara-Rudy model of human ventricular electrophysiology and the MechChem model of 
sarcomere mechanics31.
If the mechanisms behind these changes are understood, a possible practical implication 
of our findings may be that brief interruption of CRT can be used as a diagnostic test to 
observe changes in T wave area, which may yield insight into molecular changes in the 
myocardium of the patient. Because these changes occur relatively fast (within 2 weeks), one 
does not need to wait for 3-6 months, which is the period used to evaluate CRT response 
echocardiographically32, in order to consider potential adjustments to the therapy.
CRT during mitral regurgitation
MR often occurs in patients with heart failure, and its severity is linked to QRS duration33,34. CRT 
may be able to reduce dyssynchrony-related (functional) MR through several mechanisms33. 
Firstly, the closing force exerted on the mitral valve leaflets (by ventricular contraction) may 
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increase due to the more efficient cardiac contraction35. Secondly, resynchronization of 
the papillary muscles may result in improved positioning of the valve leaflets, optimizing 
valve closure36. Thirdly, a reduction in the size of the mitral orifice may reduce MR37. Finally, 
diastolic MR may be reduced by an improvement in the relative timing of atrial and ventricular 
contraction38.
However, it is not yet clear whether CRT may benefit patients with structural MR, which is not 
related to dyssynchronous contraction39. Our study in the MR+LBBB dog model (chapter 5) 
shows that CRT could still be beneficial in patients with LBBB and structural MR. The most 
likely mechanism for this improvement is resynchronization of ventricular contraction, i.e. 
counteracting the negative effects of LBBB.
It is important to remember, however, that the increase in LVdP/dtmax we observed may not 
directly indicate more forward flow. Most importantly, CRT led to either an increase in LVdP/dtmax 
or a decrease in LV end-diastolic pressure and in most cases both. This indicates alleviation of 
either forward or backward failure or both, but the exact mechanism and its effects on cardiac 
output remain to be investigated.
Moreover, it is not yet known whether acute positive effects of CRT on cardiac dyssynchrony in 
patients with LBBB and structural MR would also lead to long-term reverse cardiac remodelling 
and improved clinical outcomes. Earlier studies describing effects of CRT in the context of MR 
often excluded patients with structural MR36,40–42.
If a reduction in MR does indeed lead to better CRT outcomes, one could propose that residual 
MR after CRT should be treated using mitral valve repair. The COAPT trial supports this idea, 
since it demonstrated that patients who had previously received CRT could still derive benefit 
from a MitraClip device over optimal medical therapy alone in relation to the combined end 
point of heart failure hospitalizations and all-cause mortality43. However, another study showed 
that implantation of a MitraClip device did not seem to have a large beneficial effect in CRT 
non-responders who also suffer from significant MR44. An important difference between these 
two studies is that the latter did not include a control group but predicted survival scores 
using patient characteristics, while the former directly compared MitraClip plus optimal medical 
therapy with optimal medical therapy alone. Moreover, the group sizes were very different (614 
vs. 42 patients).
The finding that CRT may even be effective in the volume-overloaded dyssynchronous ventricle 
could also be good news for patients with rToF, who often have right bundle branch block (RBBB) 
and pulmonary insufficiency following repair45. A study in dog hearts suggests that RBBB may 
have more severe negative effects on cardiac function in the presence of RV hypertrophy, 
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created by juvenile pulmonary banding46. Conversely, counteracting RBBB through CRT may 
be extra beneficial for cardiac function in this scenario, which can occur in rToF patients due to 
remaining pulmonary stenosis and concomitant RV pressure overload. However, the net effect 
of the combination of pressure and volume overload during dyssynchrony and CRT remains 
to be investigated.
Future perspectives
To date, patients with structural MR are often excluded from studies focusing on CRT in the 
context of this disease36,40,42. It would be interesting to see if our findings in the animal model 
are replicated in those patients, and, more importantly, whether any short-term improvement 
also relates to long-term benefit. In practice, these findings may be of particular interest to 
patients of advanced age, who may be at higher risk of complications following mitral repair.
Conduction properties in patients with rToF
RBBB is common in ToF patients after repair surgery and can occur either proximally, due to 
the closing of the ventricular septal defect, or more distally, due to the right ventricular outflow 
tract obstruction resection or ventriculotomy47,48, or fibrosis due to RV overload. Theoretically, 
this conduction abnormality is an attractive target for CRT. However, the presence of 
myocardial scar tissue (e.g. due to the repair surgery or to RV overload) may limit the amount 
of resynchronization and the related CRT benefit49. We found that structural conduction blocks 
were rare in a small group of rToF patients and that the conduction properties of the RV 
free wall were fairly normal. Of note, these measurements were performed during open-heart 
surgery for medical reasons, more than two decades after the initial repair operation. Therefore, 
the patients we studied represent a group of heavily affected rToF patients. The absence of 
conduction blocks would allow biventricular pacing to resynchronize cardiac contraction, 
much like in patients with LBBB and RBBB of other cause.
However, the benefit of CRT in RBBB is disputed50. One of the reasons for this may be the 
fact that, in most studies, CRT benefit is quantified by assessing LV function or volume50. 
However, in rToF patients, RV function may be the proverbial bottleneck hampering cardiac 
function, suggesting that CRT benefits may be assessed more clearly when focusing on this 
ventricle48,50.
Another reason for the apparent lack of benefit of CRT in RBBB may be related to lead location50. 
While placing leads on the LV free wall and in the RV apex may be beneficial for LBBB, this 
may not be the optimum lead configuration for patients with RBBB50. Computer simulations 
demonstrated that traditional CRT was hardly beneficial in patients with isolated RBBB if no 
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LBBB was present50. A study in patients with congenital heart disease and RBBB found that 
pacing from a site of late activation in the RV yielded superior haemodynamic benefit over RV 
apical pacing, underlining the importance of exploring alternative lead locations51. Pacing the 
RV from a site of late activation was also found to be beneficial in other studies52,53.
Two studies found, however, that RV only pacing in rToF did not lead to cardiac 
resynchronization54,55. However, in one of these studies, the lead was not necessarily placed 
in a site of late activation54, while in the other study, a relatively short atrioventricular (AV) delay 
was used (70% of the intrinsic PR interval)55. The study by Plymen et al. used a longer AV delay 
(close to 90% of the intrinsic PR interval), potentially yielding more fusion with the intrinsic 
activation wavefront and thus more effective resynchronization51.
Nonetheless, it is not yet clear whether RV only pacing would be sufficient in rToF. LV activation 
can also be abnormal in patients with rToF, either due to scarring56 or left anterior hemiblock57. 
In our study, we did find that the four rToF patients we studied with the epicardial sock array 
had a region of late activation anteriorly in the LV, although it was small in two patients. 
However, the average LV activation time in the rToF patients was not very different from the 
non-bundle branch block (non-BBB) patients (Chapter 6, Figure 5B), which would suggest 
that LV activation in the rToF patients was fairly normal. However, it is important to remember 
that the non-BBB patients in this study also underwent electrical mapping to search for foci of 
arrhythmia, indicating that they were not healthy controls.
Besides RV pacing, also biventricular pacing may lead to electrical resynchronization in rToF 
patients54,58, but it is not clear whether this type of resynchronization is superior to RV only 
pacing from a site of late activation.
Regardless of the optimum pacing site and setting, RBBB may negatively affect cardiac 
function, and dyssynchrony may be an even more important limiting factor than pulmonary 
insufficiency for exercise capacity in patients with rToF59. The aetiology of RBBB in rToF (surgical) 
is different from RBBB in the general population, which is linked to degenerative cardiac 
disease60 and therefore potentially to tissue properties that may preclude CRT response. From 
that perspective, rToF patients may benefit more from CRT than other RBBB patients.
Future perspectives
If CRT were to become a treatment for RBBB in rToF, it would be important to determine 
the optimum time of implantation. Implantation immediately following surgery would have the 
advantage of prompt resynchronization, which may be important for improvement in exercise 
capacity in patients with rToF59. However, pacemaker implantation in children may carry a 
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higher risk of infection or lead malfunction than in adults61. Our study suggests that, even in 
adult patients with rToF and severe arrhythmias, cardiac conduction properties do not preclude 
successful resynchronization.
Conclusions
The goal of this thesis was to provide some insight into relatively unexplored aspects of CRT. 
Our results indicate that repolarization remodelling after starting CRT occurs rapidly 
and may lead to lower dispersion of repolarization. Additionally, more repolarization 
remodelling may be linked to a better echocardiographic response to CRT. 
In a dog model, we also found evidence that CRT still increases LV pump function 
in the presence of structural MR. Finally, our studies show that structural conduction 
blocks are rare in patients with rToF and that tissue properties of the right ventricular 
free wall are comparable between rToF patients and LBBB or non-BBB patients. 
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Normal activation of the cardiac ventricles comes about through a specialized, high-velocity 
conduction system. The first part of this system is the His bundle, which consists of a left and 
a right bundle branch. Conduction through these branches enables synchronized and fast 
activation of both left and right ventricles (LV and RV, respectively).
If one of the bundle branches is damaged, left bundle branch block (LBBB) or right bundle 
branch block (RBBB) occurs, and activation of the affected ventricle has to come about by 
means of slower conduction through the working myocardium. For this reason, activation and 
contraction of the affected ventricle (and in particular, its free wall) are delayed.
Over time, this activation pattern has multiple adverse consequences for the myocardium at 
the molecular and cellular level (e.g. changes to ion channels related to depolarization and 
repolarization) and at the organ level (e.g. asymmetric hypertrophy and cardiac dilatation). 
Progression of all these events leads to worsened cardiac function and more severe conduction 
delay, starting a vicious circle that can culminate in heart failure.
Cardiac resynchronization therapy (CRT) may reverse this vicious circle. This treatment involves 
implanting a pacemaker and placing electrodes in the right atrium and in both LV and RV. 
Resynchronisation through (almost) simultaneous stimulation of both ventricles can cause both 
acute and long-term improvements in cardiac function, which in turn lead to lower risk of heart 
failure hospitalisations and death, in particular in patients with heart failure and LBBB.
However, several aspects of this treatment are less well understood. First of all, while the 
effects of CRT on cardiac depolarization have been studied in considerable detail, much less 
is known about the effects of CRT on repolarization. Furthermore, much is yet to be learned 
about the efficacy of CRT in the context of structural heart disease, such as mitral regurgitation 
(MR) or congenital heart disease. The aim of the research described in this thesis was to 
branch out into these territories, hopefully yielding deeper understanding of the effects and 
potential applications of CRT.
Repolarization remodelling during CRT
Several studies have found that CRT may affect cardiac repolarization. This effect of CRT 
is particularly important since dispersion of repolarization has been linked to a higher risk of 
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cardiac arrhythmias. However, until now, the time course of repolarization remodelling after 
CRT has not been studied in detail, nor has the relation with contractile remodelling been 
elucidated.
In chapter 3 we explored the effects of CRT on repolarization by measuring T wave 
morphology changes after CRT, by relating these changes to mechanical remodelling and by 
interpreting these results using a patient-specific computational model. We found that changes 
in repolarization parameters (such as T wave area) already reached a plateau within 5 to 14 
days after initiation of CRT. However, some parameters showed contradicting results, which 
may be explained by the different aspects of repolarization represented by these parameters. 
Left ventricular ejection fraction and systolic septal strain increased between 2 weeks and 6 
months of CRT, suggesting that electrical changes precede mechanical changes.
The observed changes in the T wave were largely reproduced in a patient-specific computer 
model that assumed an inverse relation between CRT-induced change in activation time and 
adaptation in action potential duration. The latter changes resulted in a reduction in dispersion 
of repolarization during chronic CRT as compared to acute CRT.
A more detailed investigation of the link between repolarization remodelling and functional 
improvement following CRT is described in chapter 4. We analysed vectorcardiograms 
from 76 patients, both prior to the start of CRT and after six months of treatment. Then, we 
stratified the patients into two subgroups: those with a T area change smaller (LOW, indicative 
of relatively little repolarization remodelling) and larger (HIGH, indicative of more repolarization 
remodelling) than the median T area change. At baseline, the groups demonstrated comparable 
vectorcardiographic (e.g. QRS and T area) and clinical characteristics. After 6 months, most 
repolarization parameters were still comparable between the groups, except for T area and 
amplitude. Patients in the HIGH subgroup showed a larger increase in left ventricular ejection 
fraction than those in the LOW subgroup, suggesting a link between repolarization remodelling 
and mechanical changes. However, arrhythmia incidence was low and did not differ between 
the subgroups. Larger studies are required to confirm the link between T area and left ventricular 
ejection fraction, and to explore whether there is also a link between repolarization remodelling 
and clinical improvement or arrhythmia incidence.
CRT during MR
CRT may beneficially impact MR during ventricular dyssynchrony through several mechanisms. 
For example, resynchronization of contraction leads to faster build-up of pressure, while 
resynchronization of the papillary muscles may result in improved positioning of the valve 
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leaflets. While both short-term and long-term effects of CRT during MR have been reported, it 
is not yet clear whether CRT can also be beneficial during structural MR, i.e. MR that is not due 
to dyssynchrony but due to damage to the mitral valve apparatus. Moreover, it is not known 
which pacing mode would be most beneficial in this context.
In chapter 5 we explored this topic using an animal model of chronic LBBB+MR. We compared 
these animals with a control group of animals with only LBBB. Over time, echocardiographic 
and haemodynamic measurements indicated that LV end-diastolic volume was significantly 
larger in MR+LBBB dogs than in LBBB animals, while LV end-diastolic pressure also tended to 
be higher in the former. Therefore, the MR+LBBB model represents a dilated, dyssynchronous 
cardiomyopathy with MR.
After 16 weeks of LBBB, haemodynamic measurements were performed during three pacing 
modes: biventricular (BiV) pacing, LV pacing with a short atrioventricular (AV) delay (LVshort) and 
LV pacing with an AV delay aimed at fusion with intrinsic activation (LVfusion). All pacing modes 
significantly increased the maximum rate of LV pressure rise (LVdP/dtmax) in the LBBB dogs. In 
the MR+LBBB group BiV pacing tended to increase LVdP/dtmax and significantly reduced LV 
end-diastolic pressure. The different pacing modes had comparable effects.
These data suggest that CRT can be beneficial in LBBB even in the context of structural MR. 
However, extrapolating results from acute animal studies to long-term clinical effect should be 
done with care, especially since we did not measure forward blood flow into the aorta.
Conduction properties in patients with repaired 
Tetralogy of Fallot
In addition to its beneficial effects on the LV in LBBB, CRT has also been explored in patients 
with RBBB. A particular situation in which this has been attempted is after surgical repair of 
Tetralogy of Fallot (ToF), a type of congenital heart disease.
In patients with ToF, a potentially life-threatening combination of abnormalities is present in the 
heart. Very often, surgery is performed within the first year of life to repair these defects. The 
complicated repair surgery can lead to RBBB, while pressure and volume overload of the RV 
may also be present postoperatively.
Patients with repaired ToF (rToF) show both mechanical and electrical dyssynchrony. This 
suggests that resynchronization of the RV could be beneficial. RBBB is an obvious candidate 
cause of this dyssynchrony. However, fibrosis due to the combined pressure/volume overload 
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or due to surgical scars may also play a role. The distinction between these causes of 
dyssynchrony is important, since the presence of fibrotic tissue may preclude successful 
resynchronization through CRT.
In chapter 6 we investigated the cause of cardiac conduction delays in patients with rToF 
by analysing electrical mapping data that was recorded at Toronto General Hospital. During 
medically indicated cardiac surgery, more than two decades after ToF repair surgery, cardiac 
electrical activation was recorded both during sinus rhythm and during ventricular pacing. 
Thirteen patients with rToF were mapped using an endocardial RV balloon array. Epicardial 
mapping was performed in 4 of these patients, and also in 2 patients with LBBB and 2 patients 
without either LBBB or RBBB (non-BBB). We found that structural lines of block were rare in 
patients with rToF and that pacing did not increase dispersion of endocardial and epicardial 
activation of the RV free wall. Moreover, epicardial activation dispersion in both ventricles during 
pacing was quite comparable for all three groups. This suggests that myocardial conduction 
properties in rToF patients do not preclude successful resynchronization through CRT.
Conclusions
Our results indicate that repolarization remodelling after start of CRT occurs rapidly (within 
5-14 days) and, based on simulations in a patient-specific computational model, leads to lower 
dispersion of repolarization. Additionally, more repolarization remodelling may be linked to a 
better echocardiographic response to CRT.
We also found evidence that CRT still increases LV pump function in the presence of structural 
MR, even though CRT most likely does not directly influence this kind of MR.
Finally, our studies show that structural conduction blocks are rare in patients with rToF and 
that tissue properties of the right ventricular free wall are comparable between rToF patients 








The main goal of this thesis was to investigate aspects of cardiac resynchronization therapy 
(CRT) that have not yet been studied in detail. To this end we examined the effects of CRT on 
ventricular repolarization, as well as the use of this therapy in the context of structural mitral 
regurgitation (MR) and congenital heart disease.
Scientific impact
Relatively little is known about changes in the course of repolarization in the context of CRT. 
Our data provide new information in this area. Note that impulse conduction has attracted 
most attention in the field of CRT (assessed using the electrocardiogram (ECG) or mapping 
techniques), but that the processes related to conduction of the depolarization wave are 
relatively simple. In contrast, myocardial repolarization is an extremely complex process 
involving multiple ion channels, some of which (e.g. calcium channels) are also related to 
cardiac contraction. The finding that relatively simple measurements using the (ECG-based) 
vectorcardiogram provide novel information about repolarization dispersion, in particular during 
brief interruption of CRT, may open the door to further scientific studies on repolarization 
processes in the field.
These ECG-based repolarization investigations may be supported by patient-specific 
modelling. In chapter 3 an example of such an approach has been given. The full ECG (QRS 
complex and T wave) of a patient before start of CRT was fitted to a combined cardiac and 
thoracic geometrical model with ventricular conduction modelled using the Eikonal approach 
and simulated ECG based on the lead-field theory. Repeating this approach in a larger cohort 
may show differences between patients in the pre-CRT repolarization pattern.
The model was also capable of reproducing clinically observed T waves after medium-term 
follow-up. The change in T wave between the situation before initiation of CRT and after 
medium-term treatment could be explained by assuming a relation between the change in 
local activation time (AT) after CRT and the change in local action potential duration (APD)
(ΔAT – ΔAPD relation). Repeating these exercises in a larger cohort may provide evidence for 
interindividual differences in electrophysiological adaptations of the ventricles after CRT that 
may relate to response to this treatment. The latter studies may be refined by applying locally 
different ΔAT – ΔAPD relations and by including scar in the model.
On the other hand, the lack of full understanding of the mechanisms of repolarization 
remodelling calls for more basic scientific studies. These could include electrophysiological 
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measurements in cardiomyocytes that underwent long-term stretching. Another approach 
can be to use computer models with direct coupling of electrophysiological and mechanical 
properties1.
Clinical impact
Although the studies we performed either involved animals or relatively small numbers of 
patients, we hope they may be a starting point for new inquiries. One could, for example, 
study the link between repolarization remodelling and echocardiographic response in a larger 
population, and also investigate whether there may be a correlation with clinical benefit. The 
use of more detailed techniques to assess repolarization (e.g. ECG imaging) could be useful in 
this context. From a functional perspective, it also makes sense to further investigate whether 
remodelling of repolarization leads to better relaxation with longer-lasting CRT.
In the long term, a better understanding of the different conditions where CRT may be beneficial 
would be useful. If it were to be proven effective in right bundle branch block, for example, a 
potentially successful application in larger numbers of patients could be realized.
If repolarization remodelling would prove to be linked to clinical outcome, the relatively short 
time scale at which repolarization remodelling occurs (approximately 2 weeks) could enable 
faster fine-tuning of CRT settings, potentially improving its therapeutic effect.
Finally, our findings may contribute to a better understanding of how CRT impacts the heart. 
This, in turn, may help to find ways to further increase CRT efficacy, which may be advantageous 
since approximately one third of patients who receive this therapy do not respond2. If the 
mechanism or signalling pathway behind the potential link between electrical and mechanical 
remodelling were to be elucidated, this might serve as a target for drug development. Enhancing 
the response to CRT by influencing this electromechanical link could hopefully lead to further 
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